| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | VLDLR DRD1 DRD2 DRD3 CD300LF F2RL3 OR52L1 NTSR1 ADGRB1 GPR88 FAS SSTR5 IL1RL2 FCRL6 CD300C OR9A1P GHR OR51L1 LHCGR OR51B5 TAS2R1 EBI3 FCGR3A FCGR3B OR6C1 TAS2R40 FCRL5 GRIN3B IL2RB GPR151 CNR2 HRH3 | 2.04e-10 | 1353 | 133 | 32 | GO:0004888 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | TPCN2 SLC10A4 SLC17A4 SLC10A3 SLC6A7 MFSD2A SLC9A1 SLC13A1 SLC20A2 SLC4A9 SLC4A11 | 2.01e-08 | 171 | 133 | 11 | GO:0015081 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | SLC10A4 SLC17A4 SLC10A3 SLC6A7 MFSD2A SLC13A1 SLC20A2 SLC4A9 | 6.70e-08 | 81 | 133 | 8 | GO:0015370 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CALHM5 TPCN2 PIEZO1 SLC10A4 SLC17A4 COX15 SLC10A3 OTOP3 TMEM87A SLC6A7 MFSD2A SLC9A1 ATP8A1 SLC13A1 SLC20A2 GRIN3B SLC4A9 SLC4A11 | 4.40e-07 | 664 | 133 | 18 | GO:0008324 |
| GeneOntologyMolecularFunction | symporter activity | SLC10A4 SLC17A4 SLC10A3 SLC6A7 MFSD2A SLC13A1 SLC20A2 SLC4A9 SLC4A11 | 7.38e-07 | 150 | 133 | 9 | GO:0015293 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CALHM5 TPCN2 PIEZO1 SLC10A4 TMC6 SLC17A4 COX15 SLC10A3 OTOP3 TMEM87A SLC6A7 MFSD2A SLC9A1 ATP8A1 SLC13A1 SLC20A2 GRIN3B SLC4A9 SLC4A11 | 1.31e-06 | 793 | 133 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC10A4 SLC17A4 SLC10A3 SLC6A7 MFSD2A SLC13A1 SLC20A2 SLC4A9 | 1.32e-06 | 119 | 133 | 8 | GO:0015294 |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity | 2.86e-06 | 5 | 133 | 3 | GO:0004952 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC10A4 SLC17A4 COX15 SLC10A3 SLC6A7 MFSD2A SLC9A1 ATP8A1 SLC13A1 SLC20A2 SLC4A9 | 5.62e-06 | 301 | 133 | 11 | GO:0022853 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | DRD1 DRD2 DRD3 F2RL3 OR52L1 NTSR1 ADGRB1 GPR88 SSTR5 OR9A1P OR51L1 LHCGR OR51B5 TAS2R1 OR6C1 TAS2R40 GPR151 CNR2 HRH3 | 6.37e-06 | 884 | 133 | 19 | GO:0004930 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TPCN2 SLC10A4 SLC17A4 SLC10A3 TMEM87A SLC6A7 MFSD2A SLC9A1 SLC13A1 SLC20A2 GRIN3B SLC4A9 SLC4A11 | 1.41e-05 | 465 | 133 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TPCN2 SLC10A4 SLC17A4 COX15 SLC10A3 OTOP3 TMEM87A SLC6A7 MFSD2A SLC9A1 SLC13A1 SLC20A2 GRIN3B SLC4A9 SLC4A11 | 1.91e-05 | 627 | 133 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC10A4 SLC17A4 SLC10A3 SLC6A7 MFSD2A SLC9A1 SLC13A1 SLC20A2 SLC4A9 SLC4A11 | 2.98e-05 | 296 | 133 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CALHM5 TPCN2 PIEZO1 SLC10A4 TMC6 SLC17A4 COX15 SLC10A3 OTOP3 TMEM87A SLC6A7 MFSD2A SLC9A1 ATP8A1 SLC13A1 SLC20A2 GJB7 GRIN3B SLC7A10 SLC4A9 SLC4A11 | 3.45e-05 | 1180 | 133 | 21 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC10A4 SLC17A4 COX15 SLC10A3 SLC6A7 MFSD2A SLC9A1 ATP8A1 SLC13A1 SLC20A2 SLC4A9 SLC4A11 | 8.46e-05 | 477 | 133 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | transporter activity | CALHM5 TPCN2 PIEZO1 SLC10A4 TMC6 SLC17A4 COX15 SLC10A3 OTOP3 TMEM87A SLC6A7 MFSD2A SLC9A1 ATP8A1 SLC13A1 SLC20A2 GJB7 GRIN3B SLC7A10 SLC4A9 SLC4A11 | 1.22e-04 | 1289 | 133 | 21 | GO:0005215 |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity, coupled via Gi/Go | 1.32e-04 | 3 | 133 | 2 | GO:0001591 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.44e-04 | 75 | 133 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TPCN2 SLC10A4 SLC17A4 COX15 SLC10A3 OTOP3 TMEM87A SLC6A7 MFSD2A SLC9A1 SLC13A1 SLC20A2 GRIN3B SLC4A9 SLC4A11 | 1.62e-04 | 758 | 133 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 2.19e-04 | 18 | 133 | 3 | GO:0008381 | |
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 2.62e-04 | 4 | 133 | 2 | GO:0019772 | |
| GeneOntologyMolecularFunction | antigen binding | 2.87e-04 | 190 | 133 | 7 | GO:0003823 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 5.52e-04 | 100 | 133 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | cytokine binding | 6.48e-04 | 157 | 133 | 6 | GO:0019955 | |
| GeneOntologyMolecularFunction | bile acid:sodium symporter activity | 6.49e-04 | 6 | 133 | 2 | GO:0008508 | |
| GeneOntologyMolecularFunction | IgE receptor activity | 6.49e-04 | 6 | 133 | 2 | GO:0019767 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 7.86e-04 | 293 | 133 | 8 | GO:0008514 | |
| GeneOntologyMolecularFunction | immune receptor activity | 8.40e-04 | 165 | 133 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic cation channel activity | 9.05e-04 | 7 | 133 | 2 | GO:0140135 | |
| GeneOntologyMolecularFunction | IgE binding | 9.05e-04 | 7 | 133 | 2 | GO:0019863 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 9.05e-04 | 7 | 133 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | dopamine binding | 9.05e-04 | 7 | 133 | 2 | GO:0035240 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase inhibitor activity | 1.20e-03 | 8 | 133 | 2 | GO:0030292 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.44e-03 | 73 | 133 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | cytokine activity | 1.45e-03 | 250 | 133 | 7 | GO:0005125 | |
| GeneOntologyMolecularFunction | heterotrimeric G-protein binding | 1.54e-03 | 9 | 133 | 2 | GO:0032795 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.62e-03 | 35 | 133 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | phosphatase binding | 1.97e-03 | 264 | 133 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.98e-03 | 133 | 133 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.15e-03 | 268 | 133 | 7 | GO:0005539 | |
| GeneOntologyMolecularFunction | IgG binding | 2.33e-03 | 11 | 133 | 2 | GO:0019864 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.47e-03 | 140 | 133 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.51e-03 | 85 | 133 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.66e-03 | 207 | 133 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.73e-03 | 208 | 133 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 2.78e-03 | 12 | 133 | 2 | GO:0005436 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 2.86e-03 | 210 | 133 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | catecholamine binding | 3.27e-03 | 13 | 133 | 2 | GO:1901338 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 3.66e-03 | 547 | 133 | 10 | GO:0048018 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 3.80e-03 | 14 | 133 | 2 | GO:0019763 | |
| GeneOntologyMolecularFunction | arylsulfatase activity | 3.80e-03 | 14 | 133 | 2 | GO:0004065 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 3.80e-03 | 14 | 133 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | growth factor binding | 3.94e-03 | 156 | 133 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | amide binding | 3.94e-03 | 299 | 133 | 7 | GO:0033218 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 4.00e-03 | 554 | 133 | 10 | GO:0030546 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 4.04e-03 | 97 | 133 | 4 | GO:0004896 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 4.37e-03 | 15 | 133 | 2 | GO:0140161 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 5.31e-03 | 53 | 133 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | sulfuric ester hydrolase activity | 5.61e-03 | 17 | 133 | 2 | GO:0008484 | |
| GeneOntologyMolecularFunction | hexosaminidase activity | 5.61e-03 | 17 | 133 | 2 | GO:0015929 | |
| GeneOntologyMolecularFunction | flippase activity | 5.61e-03 | 17 | 133 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.79e-03 | 171 | 133 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 6.06e-03 | 324 | 133 | 7 | GO:0005126 | |
| GeneOntologyMolecularFunction | CCR chemokine receptor binding | 6.19e-03 | 56 | 133 | 3 | GO:0048020 | |
| GeneOntologyMolecularFunction | lipid binding | CYP4F8 TPCN2 CD300LF SYTL2 ADGRB1 CAV1 GHR CD1B SLC9A1 FCGR3A FCGR3B CDIPT BPIFB2 SOAT2 | 6.19e-03 | 988 | 133 | 14 | GO:0008289 |
| GeneOntologyMolecularFunction | peptidoglycan binding | 6.99e-03 | 19 | 133 | 2 | GO:0042834 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 6.99e-03 | 19 | 133 | 2 | GO:0015355 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 7.73e-03 | 20 | 133 | 2 | GO:0034185 | |
| GeneOntologyBiologicalProcess | adaptive immune response | TRGV1 TRGV2 TRGV3 TRGV4 TRGV5 FAS IGLV10-54 IGLV9-49 IL23A IGLV6-57 IGLV5-39 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 CD1B IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 EBI3 FCGR3A FCGR3B IGKV3D-20 CCL19 IL2RB IGKV3-20 | 3.00e-11 | 838 | 145 | 27 | GO:0002250 |
| GeneOntologyBiologicalProcess | immunoglobulin production | FAS IGLV10-54 IGLV9-49 IGLV6-57 IGLV5-39 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 IGKV3-20 | 1.65e-10 | 241 | 145 | 15 | GO:0002377 |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | FAS IGLV10-54 IGLV9-49 IGLV6-57 IGLV5-39 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 FCGR3A FCGR3B IGKV3D-20 IGKV3-20 | 3.77e-09 | 403 | 145 | 17 | GO:0002440 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | DRD1 DRD2 DRD3 CALHM5 TPCN2 F2RL3 PIEZO1 NTSR1 SLC17A4 COX15 OTOP3 CAV1 LHCGR SLC6A7 SLC9A1 ATP8A1 SLC13A1 SLC20A2 FCRL5 CCL19 GRIN3B CX3CL1 SLC4A9 SLC4A11 | 4.18e-08 | 942 | 145 | 24 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | DRD1 DRD2 DRD3 CALHM5 TPCN2 F2RL3 PIEZO1 TMC6 NTSR1 SLC17A4 COX15 OTOP3 CAV1 LHCGR SLC6A7 SLC9A1 ATP8A1 SLC13A1 SLC20A2 FCRL5 CCL19 GRIN3B CX3CL1 SLC4A9 SLC4A11 | 2.43e-07 | 1115 | 145 | 25 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | DRD1 DRD2 DRD3 CALHM5 TPCN2 F2RL3 PIEZO1 SLC10A4 NTSR1 SLC17A4 COX15 OTOP3 CAV1 LHCGR SLC6A7 SLC9A1 ATP8A1 SLC13A1 SLC20A2 FCRL5 CCL19 GRIN3B CX3CL1 SLC4A9 SLC4A11 | 4.85e-07 | 1157 | 145 | 25 | GO:0006812 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 9.33e-07 | 146 | 145 | 9 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 9.88e-07 | 147 | 145 | 9 | GO:0051283 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | DRD1 DRD2 DRD3 CALHM5 TPCN2 F2RL3 PIEZO1 SLC10A4 TMC6 NTSR1 SLC17A4 COX15 OTOP3 CAV1 LHCGR SLC6A7 SLC9A1 ATP8A1 SLC13A1 SLC20A2 FCRL5 CCL19 GRIN3B CX3CL1 SLC4A9 SLC4A11 HRH3 | 1.01e-06 | 1374 | 145 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 1.11e-06 | 149 | 145 | 9 | GO:0051282 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.38e-06 | 153 | 145 | 9 | GO:0051208 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 SLC17A4 COX15 OTOP3 CAV1 LHCGR SLC6A7 SLC9A1 SLC13A1 SLC20A2 FCRL5 CCL19 GRIN3B CX3CL1 SLC4A9 SLC4A11 | 1.97e-06 | 922 | 145 | 21 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 CA14 CAV1 APP LHCGR SLC9A1 CST2 FCRL5 CCL19 CX3CL1 SLC4A9 HYAL2 SLC4A11 | 2.36e-06 | 705 | 145 | 18 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 CA14 CAV1 APP LHCGR SLC9A1 CST2 FCRL5 CCL19 CX3CL1 SLC4A9 HYAL2 SLC4A11 | 2.99e-06 | 717 | 145 | 18 | GO:0050801 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 3.23e-06 | 217 | 145 | 10 | GO:0097553 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 3.37e-06 | 218 | 145 | 10 | GO:1903169 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 CAV1 APP LHCGR CST2 FCRL5 CCL19 CX3CL1 | 3.82e-06 | 389 | 145 | 13 | GO:0055074 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 CAV1 LHCGR SLC9A1 FCRL5 CCL19 GRIN3B CX3CL1 | 4.16e-06 | 392 | 145 | 13 | GO:0070588 |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 4.20e-06 | 93 | 145 | 7 | GO:0040014 | |
| GeneOntologyBiologicalProcess | arachidonate secretion | 5.07e-06 | 36 | 145 | 5 | GO:0050482 | |
| GeneOntologyBiologicalProcess | arachidonate transport | 5.07e-06 | 36 | 145 | 5 | GO:1903963 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 SLC17A4 COX15 OTOP3 CAV1 LHCGR SLC6A7 SLC9A1 SLC13A1 SLC20A2 FCRL5 CCL19 GRIN3B CX3CL1 SLC4A9 SLC4A11 | 8.96e-06 | 1017 | 145 | 21 | GO:0098660 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 CAV1 APP LHCGR FCRL5 CCL19 CX3CL1 | 9.14e-06 | 359 | 145 | 12 | GO:0006874 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 1.20e-05 | 109 | 145 | 7 | GO:1904427 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid transport | 1.36e-05 | 74 | 145 | 6 | GO:0015909 | |
| GeneOntologyBiologicalProcess | lipid transport | VLDLR DRD2 DRD3 TPCN2 CYP19A1 SLC10A4 NTSR1 SLC10A3 CAV1 LHCGR MFSD2A ATP8A1 SOAT2 HRH3 | 1.38e-05 | 506 | 145 | 14 | GO:0006869 |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 1.53e-05 | 259 | 145 | 10 | GO:0051651 | |
| GeneOntologyBiologicalProcess | organic anion transport | DRD2 DRD3 FOLR1 SLC10A4 NTSR1 SLC17A4 SLC10A3 LHCGR SLC6A7 MFSD2A SLC7A10 SLC4A9 SLC4A11 HRH3 | 1.68e-05 | 515 | 145 | 14 | GO:0015711 |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | DRD1 DRD2 DRD3 F2RL3 NTSR1 CAV1 LHCGR SLC9A1 FCRL5 GRIN3B CX3CL1 | 1.84e-05 | 323 | 145 | 11 | GO:0051924 |
| GeneOntologyBiologicalProcess | positive regulation of release of sequestered calcium ion into cytosol | 2.15e-05 | 48 | 145 | 5 | GO:0051281 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter uptake | 2.23e-05 | 24 | 145 | 4 | GO:0051580 | |
| GeneOntologyBiologicalProcess | metal ion transport | DRD1 DRD2 DRD3 TPCN2 F2RL3 SLC10A4 NTSR1 SLC17A4 CAV1 LHCGR SLC6A7 SLC9A1 SLC13A1 SLC20A2 FCRL5 CCL19 GRIN3B CX3CL1 SLC4A9 SLC4A11 | 2.37e-05 | 1000 | 145 | 20 | GO:0030001 |
| GeneOntologyBiologicalProcess | sodium ion transport | DRD2 TPCN2 SLC10A4 SLC17A4 SLC6A7 SLC9A1 SLC13A1 SLC20A2 SLC4A9 SLC4A11 | 2.56e-05 | 275 | 145 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 CAV1 APP LHCGR SLC9A1 FCRL5 CCL19 CX3CL1 SLC4A9 SLC4A11 | 2.73e-05 | 611 | 145 | 15 | GO:0030003 |
| GeneOntologyBiologicalProcess | phospholipase C-activating dopamine receptor signaling pathway | 2.77e-05 | 9 | 145 | 3 | GO:0060158 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine uptake involved in synaptic transmission | 2.77e-05 | 9 | 145 | 3 | GO:0051940 | |
| GeneOntologyBiologicalProcess | regulation of dopamine uptake involved in synaptic transmission | 2.77e-05 | 9 | 145 | 3 | GO:0051584 | |
| GeneOntologyBiologicalProcess | defense response to symbiont | TMED1 DRD2 CD300LF PGLYRP1 CST9 TRGV2 ADGRB1 TRGV3 TRGV4 TRGV5 APCS REG3G CAV1 APP IL1RL2 IL23A LRRC19 FCGR3A FCGR3B CCL19 CX3CL1 IGKV3-20 HYAL2 | 3.23e-05 | 1286 | 145 | 23 | GO:0140546 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 CAV1 APP LHCGR SLC9A1 CST2 FCRL5 CCL19 CX3CL1 HYAL2 | 3.35e-05 | 622 | 145 | 15 | GO:0098771 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 CAV1 APP LHCGR SLC9A1 FCRL5 CCL19 CX3CL1 SLC4A9 SLC4A11 | 3.35e-05 | 622 | 145 | 15 | GO:0006873 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 3.57e-05 | 286 | 145 | 10 | GO:0007188 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | DRD1 DRD2 DRD3 F2RL3 OR52L1 NTSR1 ADGRB1 CAV1 APP GPR88 SSTR5 OR9A1P OR51L1 LHCGR SLIT2 OR51B5 TAS2R1 OR6C1 TAS2R40 CCL19 CX3CL1 GPR151 CNR2 HRH3 | 3.97e-05 | 1395 | 145 | 24 | GO:0007186 |
| GeneOntologyBiologicalProcess | negative regulation of cell migration | DRD1 DRD2 MIA3 GDF15 CYP19A1 ADGRB1 CAV1 FAS SLIT2 CDH1 CX3CL1 HYAL2 | 4.19e-05 | 419 | 145 | 12 | GO:0030336 |
| GeneOntologyBiologicalProcess | icosanoid secretion | 4.59e-05 | 56 | 145 | 5 | GO:0032309 | |
| GeneOntologyBiologicalProcess | lipid localization | VLDLR DRD2 DRD3 TPCN2 CYP19A1 SLC10A4 NTSR1 SLC10A3 CAV1 LHCGR MFSD2A ATP8A1 SOAT2 HRH3 | 4.64e-05 | 565 | 145 | 14 | GO:0010876 |
| GeneOntologyBiologicalProcess | perforin production | 4.91e-05 | 2 | 145 | 2 | GO:0035944 | |
| GeneOntologyBiologicalProcess | negative regulation of cell motility | DRD1 DRD2 MIA3 GDF15 CYP19A1 ADGRB1 CAV1 FAS SLIT2 CDH1 CX3CL1 HYAL2 | 6.00e-05 | 435 | 145 | 12 | GO:2000146 |
| GeneOntologyBiologicalProcess | import into cell | VLDLR DRD1 DRD2 DRD3 TPCN2 CD300LF FOLR1 NTSR1 ADGRB1 CAV1 APP GHR SLC6A7 SLC9A1 ATP8A1 VPS33B FCGR3A FCGR3B CCL19 IL2RB | 6.44e-05 | 1074 | 145 | 20 | GO:0098657 |
| GeneOntologyBiologicalProcess | calcium ion transport | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 CAV1 LHCGR SLC9A1 FCRL5 CCL19 GRIN3B CX3CL1 | 6.45e-05 | 509 | 145 | 13 | GO:0006816 |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol | 6.73e-05 | 98 | 145 | 6 | GO:0051279 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 6.94e-05 | 61 | 145 | 5 | GO:0007187 | |
| GeneOntologyBiologicalProcess | negative regulation of locomotion | DRD1 DRD2 MIA3 GDF15 CYP19A1 ADGRB1 CAV1 FAS SLIT2 CDH1 CX3CL1 HYAL2 | 9.01e-05 | 454 | 145 | 12 | GO:0040013 |
| GeneOntologyBiologicalProcess | catecholamine uptake involved in synaptic transmission | 9.24e-05 | 13 | 145 | 3 | GO:0051934 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential migration | 9.24e-05 | 13 | 145 | 3 | GO:0021826 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential interneuron migration | 9.24e-05 | 13 | 145 | 3 | GO:0021843 | |
| GeneOntologyBiologicalProcess | dopamine uptake involved in synaptic transmission | 9.24e-05 | 13 | 145 | 3 | GO:0051583 | |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 1.04e-04 | 35 | 145 | 4 | GO:0071875 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 1.10e-04 | 154 | 145 | 7 | GO:0051928 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.14e-04 | 208 | 145 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | maintenance of location | DRD1 DRD2 TPCN2 F2RL3 NTSR1 CAV1 LHCGR FCRL5 CCL19 CX3CL1 SOAT2 | 1.16e-04 | 396 | 145 | 11 | GO:0051235 |
| GeneOntologyBiologicalProcess | regulation of leukocyte migration | 1.17e-04 | 267 | 145 | 9 | GO:0002685 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transport | 1.25e-04 | 69 | 145 | 5 | GO:1903170 | |
| GeneOntologyBiologicalProcess | defense response to other organism | TMED1 DRD2 CD300LF PGLYRP1 CST9 TRGV2 ADGRB1 TRGV3 TRGV4 TRGV5 APCS REG3G CAV1 APP IL1RL2 IL23A LRRC19 FCGR3A FCGR3B CCL19 CX3CL1 IGKV3-20 HYAL2 | 1.27e-04 | 1407 | 145 | 23 | GO:0098542 |
| GeneOntologyBiologicalProcess | learning | 1.30e-04 | 212 | 145 | 8 | GO:0007612 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 1.35e-04 | 213 | 145 | 8 | GO:0015718 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 1.39e-04 | 337 | 145 | 10 | GO:0006898 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | DRD2 DRD3 FOLR1 SLC10A4 NTSR1 SLC10A3 LHCGR SLC6A7 MFSD2A SLC7A10 HRH3 | 1.57e-04 | 410 | 145 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | DRD2 DRD3 FOLR1 SLC10A4 NTSR1 SLC10A3 LHCGR SLC6A7 MFSD2A SLC7A10 HRH3 | 1.63e-04 | 412 | 145 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | icosanoid transport | 1.64e-04 | 73 | 145 | 5 | GO:0071715 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | DRD1 DRD2 DRD3 TPCN2 F2RL3 NTSR1 CA14 CAV1 APP SSTR5 TLCD2 LHCGR SLC9A1 CST2 FCRL5 CCL19 CX3CL1 SLC4A9 SOAT2 HYAL2 SLC4A11 | 1.75e-04 | 1249 | 145 | 21 | GO:0048878 |
| GeneOntologyBiologicalProcess | response to amphetamine | 1.76e-04 | 40 | 145 | 4 | GO:0001975 | |
| GeneOntologyBiologicalProcess | detection of stimulus | PGLYRP1 CDHR2 PIEZO1 OR52L1 NTSR1 REG3G GPR88 TMEM87A OR9A1P OR51L1 OR51B5 TAS2R1 OR6C1 CST2 TAS2R40 | 1.76e-04 | 722 | 145 | 15 | GO:0051606 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.98e-04 | 76 | 145 | 5 | GO:0030199 | |
| GeneOntologyBiologicalProcess | cognition | VLDLR DRD1 DRD2 DRD3 NTSR1 APP GPR88 LHCGR MFSD2A ATP8A1 HRH3 | 2.05e-04 | 423 | 145 | 11 | GO:0050890 |
| GeneOntologyBiologicalProcess | positive regulation of transport | DRD1 DRD2 CD300LF F2RL3 CYP19A1 NTSR1 SYTL2 CAV1 APP LHCGR SLC9A1 ATP8A1 PGAP1 CCL19 CDH1 CX3CL1 IL2RB HYAL2 HRH3 | 2.10e-04 | 1081 | 145 | 19 | GO:0051050 |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | DRD1 DRD2 DRD3 TPCN2 CYP19A1 SLC10A4 SLC10A3 CAV1 SOAT2 HRH3 | 2.27e-04 | 358 | 145 | 10 | GO:0015850 |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 2.34e-04 | 174 | 145 | 7 | GO:1904064 | |
| GeneOntologyBiologicalProcess | endocytosis | VLDLR DRD2 DRD3 TPCN2 CD300LF FOLR1 ADGRB1 CAV1 APP GHR ATP8A1 VPS33B FCGR3A FCGR3B CCL19 IL2RB | 2.39e-04 | 827 | 145 | 16 | GO:0006897 |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | GDF5 DRD1 DRD2 DRD3 SPRED2 CD300LF PGLYRP1 GDF15 PROCR CYP19A1 ADGRB1 APCS REG3G APP FAS IL23A SLIT2 ORM1 CST2 TWSG1 CDH1 CX3CL1 CNR2 | 2.86e-04 | 1488 | 145 | 23 | GO:0051241 |
| GeneOntologyBiologicalProcess | negative regulation of dopamine receptor signaling pathway | 2.92e-04 | 4 | 145 | 2 | GO:0060160 | |
| GeneOntologyBiologicalProcess | leukocyte migration | MIA3 NUP85 GDF15 CYP19A1 ITGA2B APP IL23A SLIT2 CCL19 CX3CL1 CNR2 | 3.41e-04 | 449 | 145 | 11 | GO:0050900 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 3.42e-04 | 377 | 145 | 10 | GO:0030198 | |
| GeneOntologyBiologicalProcess | fatty acid transport | 3.44e-04 | 132 | 145 | 6 | GO:0015908 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 3.50e-04 | 378 | 145 | 10 | GO:0043062 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 3.51e-04 | 186 | 145 | 7 | GO:0019730 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 3.53e-04 | 86 | 145 | 5 | GO:0007193 | |
| GeneOntologyBiologicalProcess | prepulse inhibition | 3.55e-04 | 20 | 145 | 3 | GO:0060134 | |
| GeneOntologyBiologicalProcess | dopamine uptake | 3.55e-04 | 20 | 145 | 3 | GO:0090494 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 3.57e-04 | 379 | 145 | 10 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor production | 3.59e-04 | 133 | 145 | 6 | GO:0032760 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic cation transmembrane transport | 3.64e-04 | 380 | 145 | 10 | GO:1904062 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 4.12e-04 | 191 | 145 | 7 | GO:0007189 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor internalization | 4.12e-04 | 21 | 145 | 3 | GO:0002031 | |
| GeneOntologyBiologicalProcess | catecholamine uptake | 4.12e-04 | 21 | 145 | 3 | GO:0090493 | |
| GeneOntologyBiologicalProcess | dendritic cell antigen processing and presentation | 4.12e-04 | 21 | 145 | 3 | GO:0002468 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor superfamily cytokine production | 4.20e-04 | 137 | 145 | 6 | GO:1903557 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 4.25e-04 | 192 | 145 | 7 | GO:0034767 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen levels | 4.66e-04 | 195 | 145 | 7 | GO:0071453 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transport | 4.82e-04 | 92 | 145 | 5 | GO:0051926 | |
| GeneOntologyBiologicalProcess | cellular response to hyperoxia | 4.84e-04 | 5 | 145 | 2 | GO:0071455 | |
| GeneOntologyCellularComponent | immunoglobulin complex | IGLV10-54 IGLV9-49 IGLV6-57 IGLV5-39 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 IGKV3-20 | 1.22e-11 | 166 | 147 | 14 | GO:0019814 |
| GeneOntologyCellularComponent | cell surface | VLDLR DRD1 CD248 FOLR1 PROCR NTSR1 TRGV1 TRGV2 TRGV3 TRGV4 TRGV5 CAV1 ITGA2B APP FAS FCRL6 GHR SLIT2 CD1B SLC9A1 EBI3 FCGR3A FCGR3B FCRL5 CCL19 CDH1 CX3CL1 IL2RB HYAL2 | 7.53e-10 | 1111 | 147 | 29 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | CD248 FOLR1 TRGV1 TRGV2 TRGV3 TRGV4 TRGV5 ITGA2B FAS FCRL6 GHR CD1B EBI3 FCGR3A FCGR3B FCRL5 CCL19 IL2RB HYAL2 | 4.48e-09 | 519 | 147 | 19 | GO:0009897 |
| GeneOntologyCellularComponent | apical part of cell | VLDLR CYP4F8 DRD3 CDHR2 FOLR1 SLC17A4 REG3G CA14 CAV1 APP FAS SLC9A1 SLC13A1 SLC20A2 CDH1 SLC4A9 HYAL2 SLC4A11 | 1.94e-07 | 592 | 147 | 18 | GO:0045177 |
| GeneOntologyCellularComponent | side of membrane | CD248 FOLR1 NTSR1 TRGV1 TRGV2 TRGV3 TRGV4 TRGV5 ITGA2B FAS FCRL6 GHR CD1B EBI3 FCGR3A FCGR3B FCRL5 CCL19 CDH1 IL2RB HYAL2 CNR2 | 2.10e-07 | 875 | 147 | 22 | GO:0098552 |
| GeneOntologyCellularComponent | receptor complex | VLDLR DRD1 DRD2 TRGV1 TRGV2 TRGV3 TRGV4 TRGV5 ITGA2B APP GHR LHCGR EBI3 FCRL5 GRIN3B IL2RB | 3.49e-06 | 581 | 147 | 16 | GO:0043235 |
| GeneOntologyCellularComponent | plasma membrane protein complex | DRD1 DRD2 SGCA TRGV1 TRGV2 TRGV3 TRGV4 TRGV5 CAV1 ITGA2B FAS FCGR3A FCGR3B GJB7 GRIN3B CDH1 IL2RB | 3.87e-05 | 785 | 147 | 17 | GO:0098797 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.24e-04 | 332 | 147 | 10 | GO:0005788 | |
| GeneOntologyCellularComponent | apical plasma membrane | CYP4F8 CDHR2 FOLR1 SLC17A4 CA14 CAV1 FAS SLC9A1 SLC13A1 SLC20A2 HYAL2 SLC4A11 | 1.75e-04 | 487 | 147 | 12 | GO:0016324 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 1.90e-04 | 350 | 147 | 10 | GO:0098802 | |
| GeneOntologyCellularComponent | membrane raft | 2.49e-04 | 362 | 147 | 10 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 2.61e-04 | 364 | 147 | 10 | GO:0098857 | |
| GeneOntologyCellularComponent | Fc-gamma receptor III complex | 2.92e-04 | 4 | 147 | 2 | GO:0033001 | |
| GeneOntologyCellularComponent | membrane protein complex | DRD1 DRD2 TPCN2 SGCA MARCHF6 TRGV1 TRGV2 TRGV3 TRGV4 TRGV5 COX15 CAV1 ITGA2B FAS PIGQ SLC9A1 VPS33B FCGR3A FCGR3B GJB7 GRIN3B CDH1 IL2RB | 3.19e-04 | 1498 | 147 | 23 | GO:0098796 |
| GeneOntologyCellularComponent | exocytic vesicle | 4.48e-04 | 320 | 147 | 9 | GO:0070382 | |
| GeneOntologyCellularComponent | secretory vesicle | DRD2 KLK10 PGLYRP1 CYP19A1 SLC10A4 TMC6 SYTL2 REG3G CAV1 ITGA2B APP FAS SLC6A7 ORM1 ORM2 ATP8A1 VPS33B FCGR3B KLK13 GPR151 | 4.65e-04 | 1246 | 147 | 20 | GO:0099503 |
| GeneOntologyCellularComponent | dopaminergic synapse | 4.76e-04 | 22 | 147 | 3 | GO:0098691 | |
| GeneOntologyCellularComponent | platelet alpha granule | 5.08e-04 | 93 | 147 | 5 | GO:0031091 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS3 CD248 GDF15 APCS REG3G MMP21 VWA1 SLIT2 ORM1 ORM2 LOX CST2 LRRN2 | 7.55e-04 | 656 | 147 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS3 CD248 GDF15 APCS REG3G MMP21 VWA1 SLIT2 ORM1 ORM2 LOX CST2 LRRN2 | 7.76e-04 | 658 | 147 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | transport vesicle | DRD2 SPRED2 FOLR1 CYP19A1 SLC10A4 SYTL2 APP SLC6A7 ATP8A1 VPS33B GPR151 | 1.13e-03 | 519 | 147 | 11 | GO:0030133 |
| GeneOntologyCellularComponent | synaptic vesicle | 1.31e-03 | 300 | 147 | 8 | GO:0008021 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex, circulating | 1.34e-03 | 8 | 147 | 2 | GO:0071754 | |
| GeneOntologyCellularComponent | pentameric IgM immunoglobulin complex | 1.34e-03 | 8 | 147 | 2 | GO:0071756 | |
| GeneOntologyCellularComponent | monomeric IgA immunoglobulin complex | 1.71e-03 | 9 | 147 | 2 | GO:0071748 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | TMED1 CYP4F8 DRD1 MIA3 FOLR1 CYP19A1 PIEZO1 TMC6 MARCHF6 CAV1 PIGQ MFSD2A FICD HHAT PGAP1 CDIPT GRIN3B RNF145 SOAT2 | 1.83e-03 | 1293 | 147 | 19 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | TMED1 CYP4F8 DRD1 MIA3 FOLR1 CYP19A1 PIEZO1 TMC6 MARCHF6 CAV1 PIGQ MFSD2A FICD HHAT PGAP1 CDIPT GRIN3B RNF145 SOAT2 | 1.93e-03 | 1299 | 147 | 19 | GO:0098827 |
| GeneOntologyCellularComponent | polymeric IgA immunoglobulin complex | 2.13e-03 | 10 | 147 | 2 | GO:0071749 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex, circulating | 2.13e-03 | 10 | 147 | 2 | GO:0071746 | |
| GeneOntologyCellularComponent | secretory IgA immunoglobulin complex | 2.13e-03 | 10 | 147 | 2 | GO:0071751 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | TMED1 CYP4F8 DRD1 MIA3 FOLR1 CYP19A1 PIEZO1 TMC6 MARCHF6 CAV1 PIGQ MFSD2A FICD HHAT PGAP1 CDIPT GRIN3B RNF145 SOAT2 | 2.45e-03 | 1327 | 147 | 19 | GO:0042175 |
| GeneOntologyCellularComponent | G protein-coupled receptor complex | 2.59e-03 | 11 | 147 | 2 | GO:0097648 | |
| GeneOntologyCellularComponent | brush border membrane | 2.81e-03 | 83 | 147 | 4 | GO:0031526 | |
| GeneOntologyCellularComponent | Fc receptor complex | 3.10e-03 | 12 | 147 | 2 | GO:0032997 | |
| GeneOntologyCellularComponent | blood microparticle | 3.53e-03 | 144 | 147 | 5 | GO:0072562 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.34e-03 | 530 | 147 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | brush border | 4.45e-03 | 152 | 147 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 4.76e-03 | 293 | 147 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex | 4.86e-03 | 15 | 147 | 2 | GO:0071745 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex | 4.86e-03 | 15 | 147 | 2 | GO:0071753 | |
| GeneOntologyCellularComponent | secretory granule | DRD2 KLK10 PGLYRP1 TMC6 REG3G CAV1 ITGA2B APP FAS ORM1 ORM2 ATP8A1 VPS33B FCGR3B KLK13 | 5.25e-03 | 1014 | 147 | 15 | GO:0030141 |
| GeneOntologyCellularComponent | specific granule | 5.51e-03 | 160 | 147 | 5 | GO:0042581 | |
| GeneOntologyCellularComponent | T cell receptor complex | 5.96e-03 | 163 | 147 | 5 | GO:0042101 | |
| GeneOntologyCellularComponent | neuronal cell body | DRD1 DRD2 CYP19A1 NTSR1 APP FAS GHR SLIT2 CST2 GRIN3B CX3CL1 SLC7A10 CNR2 | 6.11e-03 | 835 | 147 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 6.23e-03 | 17 | 147 | 2 | GO:0042571 | |
| GeneOntologyCellularComponent | dendritic spine | 7.39e-03 | 242 | 147 | 6 | GO:0043197 | |
| MousePheno | digestive/alimentary phenotype | CYP4F8 DRD2 SPRED2 PNLIP PGLYRP1 ADAMTS3 FOLR1 CYP19A1 NTSR1 SYTL2 REG3G MMP21 CAV1 ITGA2B FAS IL1RL2 IL23A LHCGR SLIT2 SLC9A1 EBI3 HHAT PGAP1 TWSG1 CDH1 SLC4A9 SOAT2 HYAL2 CNR2 | 7.38e-07 | 1500 | 103 | 29 | MP:0005381 |
| MousePheno | abnormal digestive system physiology | DRD2 PNLIP PGLYRP1 CYP19A1 NTSR1 SYTL2 REG3G CAV1 ITGA2B FAS IL1RL2 IL23A SLC9A1 EBI3 CDH1 SLC4A9 SOAT2 | 1.63e-06 | 599 | 103 | 17 | MP:0001663 |
| MousePheno | increased circulating prolactin level | 2.12e-05 | 8 | 103 | 3 | MP:0005124 | |
| MousePheno | increased prolactin level | 3.16e-05 | 9 | 103 | 3 | MP:0005139 | |
| MousePheno | disproportionate dwarf | 6.08e-05 | 57 | 103 | 5 | MP:0002427 | |
| MousePheno | abnormal susceptibility to autoimmune disorder | CD300LF PGLYRP1 CYP19A1 FAS IL23A GHR FCGR3A FCGR3B IL2RB HRH3 | 8.76e-05 | 307 | 103 | 10 | MP:0002425 |
| MousePheno | decreased locomotor activity | GDF5 DRD1 DRD2 DRD3 GDF15 NPEPPS CYP19A1 PIEZO1 CAV1 APP IL1RL2 SLC6A7 LOX GRIN3B CX3CL1 SLC7A10 HRH3 | 1.09e-04 | 829 | 103 | 17 | MP:0001402 |
| MousePheno | abnormal prolactin level | 1.22e-04 | 35 | 103 | 4 | MP:0003970 | |
| MousePheno | amyloidosis | 1.22e-04 | 35 | 103 | 4 | MP:0000604 | |
| MousePheno | abnormal amyloid deposition | 1.22e-04 | 35 | 103 | 4 | MP:0021152 | |
| MousePheno | hypoactivity | GDF5 DRD1 DRD2 DRD3 GDF15 NPEPPS CYP19A1 PIEZO1 CAV1 APP GPR88 IL1RL2 SLC6A7 MFSD2A LOX GRIN3B CX3CL1 SLC7A10 HRH3 | 1.52e-04 | 1023 | 103 | 19 | MP:0031392 |
| MousePheno | autoimmune response | CD300LF PGLYRP1 CYP19A1 APCS FAS IL23A GHR FCGR3A FCGR3B IL2RB HRH3 | 1.65e-04 | 398 | 103 | 11 | MP:0001844 |
| MousePheno | abnormal self tolerance | CD300LF PGLYRP1 CYP19A1 APCS FAS IL23A GHR FCGR3A FCGR3B IL2RB HRH3 | 1.73e-04 | 400 | 103 | 11 | MP:0005005 |
| MousePheno | abnormal immune tolerance | CD300LF PGLYRP1 CYP19A1 APCS FAS IL23A GHR FCGR3A FCGR3B IL2RB HRH3 | 1.88e-04 | 404 | 103 | 11 | MP:0005000 |
| MousePheno | decreased circulating estrogen level | 2.28e-04 | 41 | 103 | 4 | MP:0003371 | |
| Domain | Dopamine_rcpt | 3.04e-06 | 5 | 127 | 3 | IPR000929 | |
| Domain | A1A_glycop | 4.59e-05 | 2 | 127 | 2 | IPR001500 | |
| Domain | GPCR_Rhodpsn_7TM | DRD1 DRD2 DRD3 F2RL3 OR52L1 NTSR1 GPR88 SSTR5 OR51L1 LHCGR OR51B5 OR6C1 GPR151 CNR2 HRH3 | 5.06e-05 | 670 | 127 | 15 | IPR017452 |
| Domain | 7tm_1 | DRD1 DRD2 DRD3 F2RL3 OR52L1 NTSR1 GPR88 SSTR5 OR51L1 LHCGR OR51B5 OR6C1 GPR151 CNR2 HRH3 | 5.70e-05 | 677 | 127 | 15 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | DRD1 DRD2 DRD3 F2RL3 OR52L1 NTSR1 GPR88 SSTR5 OR51L1 LHCGR OR51B5 OR6C1 GPR151 CNR2 HRH3 | 6.50e-05 | 685 | 127 | 15 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | DRD1 DRD2 DRD3 F2RL3 OR52L1 NTSR1 GPR88 SSTR5 OR51L1 LHCGR OR51B5 OR6C1 GPR151 CNR2 HRH3 | 7.17e-05 | 691 | 127 | 15 | PS50262 |
| Domain | GPCR_Rhodpsn | DRD1 DRD2 DRD3 F2RL3 OR52L1 NTSR1 GPR88 SSTR5 OR51L1 LHCGR OR51B5 OR6C1 GPR151 CNR2 HRH3 | 7.29e-05 | 692 | 127 | 15 | IPR000276 |
| Domain | Ig_2 | 1.39e-04 | 73 | 127 | 5 | PF13895 | |
| Domain | - | CD300LF SGCA VWA1 IL1RL2 FCRL6 CD300C GHR CD1B EBI3 FCGR3A FCGR3B LRRN2 FCRL5 IL2RB | 1.69e-04 | 663 | 127 | 14 | 2.60.40.10 |
| Domain | TM_Fragile-X-F-assoc | 2.73e-04 | 4 | 127 | 2 | IPR019396 | |
| Domain | Tmemb_185A | 2.73e-04 | 4 | 127 | 2 | PF10269 | |
| Domain | GPR107-like | 2.73e-04 | 4 | 127 | 2 | IPR009637 | |
| Domain | Lung_7-TM_R | 2.73e-04 | 4 | 127 | 2 | PF06814 | |
| Domain | Ig-like_fold | CD300LF SGCA VWA1 IL1RL2 FCRL6 CD300C GHR CD1B EBI3 FCGR3A FCGR3B LRRN2 FCRL5 IL2RB | 3.21e-04 | 706 | 127 | 14 | IPR013783 |
| Domain | MHC_I_3 | 6.76e-04 | 6 | 127 | 2 | PF16497 | |
| Domain | BilAc:Na_symport/Acr3 | 9.42e-04 | 7 | 127 | 2 | IPR002657 | |
| Domain | SBF | 9.42e-04 | 7 | 127 | 2 | PF01758 | |
| Domain | SPR | 9.42e-04 | 7 | 127 | 2 | PS51227 | |
| Domain | Sprouty | 9.42e-04 | 7 | 127 | 2 | IPR007875 | |
| Domain | Sprouty | 9.42e-04 | 7 | 127 | 2 | PF05210 | |
| Domain | 7TM_GPCR_Srsx | 1.01e-03 | 112 | 127 | 5 | SM01381 | |
| Domain | HCO3_cotransp | 1.99e-03 | 10 | 127 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.99e-03 | 10 | 127 | 2 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 1.99e-03 | 10 | 127 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.99e-03 | 10 | 127 | 2 | IPR003020 | |
| Domain | MBOAT_fam | 2.42e-03 | 11 | 127 | 2 | IPR004299 | |
| Domain | MBOAT | 2.42e-03 | 11 | 127 | 2 | PF03062 | |
| Domain | Cystatin | 2.90e-03 | 12 | 127 | 2 | IPR027214 | |
| Domain | Znf_RING-CH | 5.84e-03 | 17 | 127 | 2 | IPR011016 | |
| Domain | SULFATASE_1 | 5.84e-03 | 17 | 127 | 2 | PS00523 | |
| Domain | LIPOCALIN | 5.84e-03 | 17 | 127 | 2 | PS00213 | |
| Domain | RINGv | 5.84e-03 | 17 | 127 | 2 | SM00744 | |
| Domain | SULFATASE_2 | 5.84e-03 | 17 | 127 | 2 | PS00149 | |
| Domain | IG_LIKE | 6.41e-03 | 491 | 127 | 9 | PS50835 | |
| Domain | Cystatin_dom | 6.54e-03 | 18 | 127 | 2 | IPR000010 | |
| Domain | Sulfatase | 6.54e-03 | 18 | 127 | 2 | PF00884 | |
| Domain | Sulfatase_N | 6.54e-03 | 18 | 127 | 2 | IPR000917 | |
| Domain | Cystatin | 6.54e-03 | 18 | 127 | 2 | PF00031 | |
| Domain | Lipocalin | 6.54e-03 | 18 | 127 | 2 | IPR002345 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | CD300LF IGLV6-57 CD300C CD1B IGLV2-14 IGLV2-11 IGLV2-8 FCGR3A IGKV3D-20 CDH1 IGKV3-20 | 2.21e-07 | 190 | 108 | 11 | M8240 |
| Pathway | WP_GPCRS_NONODORANT | DRD1 DRD2 DRD3 F2RL3 NTSR1 ADGRB1 SSTR5 LHCGR TAS2R1 TAS2R40 CNR2 HRH3 | 8.89e-07 | 266 | 108 | 12 | MM15843 |
| Pathway | REACTOME_FCGR_ACTIVATION | IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 FCGR3A IGKV3D-20 IGKV3-20 | 9.30e-07 | 69 | 108 | 7 | M27108 |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 FCGR3A IGKV3D-20 IGKV3-20 | 3.02e-06 | 82 | 108 | 7 | M27110 |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 4.32e-06 | 5 | 108 | 3 | M27301 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 4.32e-06 | 5 | 108 | 3 | MM15007 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD1 DRD2 DRD3 F2RL3 NTSR1 APP SSTR5 LHCGR TAS2R1 TAS2R40 CCL19 CX3CL1 CNR2 HRH3 | 5.00e-06 | 430 | 108 | 14 | MM15160 |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 6.93e-06 | 61 | 108 | 6 | M27581 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 7.43e-06 | 272 | 108 | 11 | M13380 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 FCGR3A IGKV3D-20 IGKV3-20 | 8.09e-06 | 95 | 108 | 7 | M29842 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | DRD1 DRD2 DRD3 F2RL3 NTSR1 APP SSTR5 LHCGR CCL19 CX3CL1 CNR2 HRH3 | 8.26e-06 | 330 | 108 | 12 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | DRD1 DRD2 DRD3 F2RL3 NTSR1 APP SSTR5 LHCGR CCL19 CX3CL1 CNR2 HRH3 | 9.06e-06 | 333 | 108 | 12 | MM14963 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD1 DRD2 DRD3 F2RL3 NTSR1 APP SSTR5 LHCGR TAS2R1 TAS2R40 CCL19 CX3CL1 CNR2 HRH3 | 1.16e-05 | 463 | 108 | 14 | M507 |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 1.42e-05 | 69 | 108 | 6 | M27150 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 1.68e-05 | 71 | 108 | 6 | M1078 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 1.68e-05 | 71 | 108 | 6 | M27203 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | PROCR CAV1 IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 SLC7A10 IGKV3-20 | 1.78e-05 | 194 | 108 | 9 | M16312 |
| Pathway | REACTOME_PARASITE_INFECTION | IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 FCGR3A IGKV3D-20 IGKV3-20 | 2.99e-05 | 116 | 108 | 7 | M29843 |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 3.34e-05 | 80 | 108 | 6 | M6121 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 5.03e-05 | 86 | 108 | 6 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 5.03e-05 | 86 | 108 | 6 | M27206 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 5.37e-05 | 87 | 108 | 6 | M27205 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 FCGR3A IGKV3D-20 IGKV3-20 | 7.53e-05 | 134 | 108 | 7 | M29840 |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.05e-04 | 98 | 108 | 6 | M27152 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 FCGR3A IGKV3D-20 IGKV3-20 | 1.13e-04 | 143 | 108 | 7 | M27107 |
| Pathway | WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION | 1.44e-04 | 254 | 108 | 9 | M48344 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.71e-04 | 260 | 108 | 9 | M39397 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 2.52e-04 | 115 | 108 | 6 | M19752 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | APP IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 FCGR3A IGKV3D-20 IGKV3-20 | 2.77e-04 | 219 | 108 | 8 | M29836 |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 2.91e-04 | 42 | 108 | 4 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 2.91e-04 | 42 | 108 | 4 | MM14971 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD1 DRD2 DRD3 F2RL3 NTSR1 APP SSTR5 LHCGR TAS2R1 TAS2R40 CCL19 CX3CL1 CNR2 HRH3 | 4.06e-04 | 646 | 108 | 14 | MM14962 |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPJ_TO_IGG_FCGR_RAC_SIGNALING_PATHWAY | 5.73e-04 | 5 | 108 | 2 | M49014 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 6.17e-04 | 136 | 108 | 6 | M27207 | |
| Pathway | REACTOME_HEMOSTASIS | F2RL3 PROCR CAV1 ITGA2B APP IGLV6-57 ORM1 ORM2 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 SLC7A10 IGKV3-20 | 6.66e-04 | 679 | 108 | 14 | M8395 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD1 DRD2 DRD3 F2RL3 NTSR1 APP SSTR5 LHCGR TAS2R1 TAS2R40 CCL19 CX3CL1 CNR2 HRH3 | 9.21e-04 | 702 | 108 | 14 | M746 |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 1.18e-03 | 154 | 108 | 6 | M39007 | |
| Pathway | WP_MONOAMINE_GPCRS | 1.68e-03 | 31 | 108 | 3 | MM15871 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.70e-03 | 289 | 108 | 8 | MM15057 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 1.73e-03 | 166 | 108 | 6 | M608 | |
| Pubmed | IGLV10-54 IGLV6-57 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 FCGR3A IGKV3D-20 IGKV3-20 | 1.37e-18 | 48 | 148 | 12 | 11955599 | |
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | IGLV10-54 IGLV9-49 IGLV6-57 IGLV5-39 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 | 1.80e-18 | 49 | 148 | 12 | 8951372 |
| Pubmed | IGLV10-54 IGLV6-57 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGKV3D-20 | 2.43e-15 | 43 | 148 | 10 | 1249422 | |
| Pubmed | IGLV10-54 IGLV6-57 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 | 4.25e-13 | 47 | 148 | 9 | 814163 | |
| Pubmed | One-megabase sequence analysis of the human immunoglobulin lambda gene locus. | IGLV10-54 IGLV9-49 IGLV6-57 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 | 1.53e-12 | 109 | 148 | 11 | 9074928 |
| Pubmed | 3.78e-09 | 15 | 148 | 5 | 2969332 | ||
| Pubmed | 3.24e-08 | 22 | 148 | 5 | 2527426 | ||
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 30103286 | ||
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 12781734 | ||
| Pubmed | Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. | 7.55e-08 | 3 | 148 | 3 | 7566118 | |
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 15016423 | ||
| Pubmed | Expression and pharmacological characterization of the human D3 dopamine receptor. | 7.55e-08 | 3 | 148 | 3 | 8301582 | |
| Pubmed | Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits. | 7.55e-08 | 3 | 148 | 3 | 12097513 | |
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 18644790 | ||
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 20452395 | ||
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 27591410 | ||
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 9354330 | ||
| Pubmed | A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice. | 7.55e-08 | 3 | 148 | 3 | 27019190 | |
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 18644244 | ||
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 26483399 | ||
| Pubmed | The first avian Ig-like Fc receptor family member combines features of mammalian FcR and FCRL. | 1.52e-07 | 12 | 148 | 4 | 17273841 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | PGLYRP1 CD248 CDHR2 FOLR1 GDF15 PROCR NPEPPS NAGA APCS VWA1 ORM1 ORM2 IGLV2-14 ATP8A1 FCGR3A FCGR3B BPIFB2 CDH1 IGKV3-20 | 1.60e-07 | 1070 | 148 | 19 | 23533145 |
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 16816977 | ||
| Pubmed | Modulation of dopamine D(2) receptor signaling by actin-binding protein (ABP-280). | 3.01e-07 | 4 | 148 | 3 | 10692483 | |
| Pubmed | Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice. | 3.01e-07 | 4 | 148 | 3 | 16476524 | |
| Pubmed | Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. | 3.01e-07 | 4 | 148 | 3 | 17251429 | |
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 33287325 | ||
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 25233244 | ||
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 15785860 | ||
| Pubmed | Dopamine receptor-mediated regulation of neuronal "clock" gene expression. | 3.01e-07 | 4 | 148 | 3 | 19017537 | |
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 18451638 | ||
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 19235789 | ||
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 12967601 | ||
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 21853233 | ||
| Pubmed | Dopaminergic signaling in the cochlea: receptor expression patterns and deletion phenotypes. | 7.50e-07 | 5 | 148 | 3 | 22219295 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 23185343 | ||
| Pubmed | Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin. | 7.50e-07 | 5 | 148 | 3 | 23242137 | |
| Pubmed | [Dopamine receptor signaling regulates human osteoclastogenesis]. | 7.50e-07 | 5 | 148 | 3 | 23445730 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 19105202 | ||
| Pubmed | Neuron-specific age-related decreases in dopamine receptor subtype mRNAs. | 7.50e-07 | 5 | 148 | 3 | 12509874 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 18083900 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 9457173 | ||
| Pubmed | Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. | 7.50e-07 | 5 | 148 | 3 | 11359830 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 26597879 | ||
| Pubmed | Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain. | 7.50e-07 | 5 | 148 | 3 | 20714340 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 18366720 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 23753418 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 17509542 | ||
| Pubmed | 1.07e-06 | 179 | 148 | 8 | 18577758 | ||
| Pubmed | Rod vision is controlled by dopamine-dependent sensitization of rod bipolar cells by GABA. | 1.50e-06 | 6 | 148 | 3 | 21982372 | |
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 19647327 | ||
| Pubmed | DISC1 regulates primary cilia that display specific dopamine receptors. | 1.50e-06 | 6 | 148 | 3 | 20531939 | |
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 16424823 | ||
| Pubmed | Early-onset schizophrenia and dopamine-related gene polymorphism. | 1.50e-06 | 6 | 148 | 3 | 12497608 | |
| Pubmed | The endothelial protein C receptor plays an essential role in the maintenance of pregnancy. | 1.50e-06 | 6 | 148 | 3 | 33158859 | |
| Pubmed | 2.46e-06 | 200 | 148 | 8 | 18240029 | ||
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | GDF5 GDF15 PROCR APCS APP FAS IL1RL2 ORM1 ORM2 CD1B BPIFB2 FCRL5 CCL19 CX3CL1 IL2RB | 2.60e-06 | 824 | 148 | 15 | 20237496 |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 26447226 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 20071033 | ||
| Pubmed | D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. | 2.61e-06 | 7 | 148 | 3 | 12181426 | |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 20672519 | ||
| Pubmed | Correlates of response to Olanzapine in a North Indian Schizophrenia sample. | 2.61e-06 | 7 | 148 | 3 | 19000940 | |
| Pubmed | Predicting sensation seeking from dopamine genes. A candidate-system approach. | 4.16e-06 | 8 | 148 | 3 | 20732903 | |
| Pubmed | 4.16e-06 | 8 | 148 | 3 | 10998124 | ||
| Pubmed | 4.16e-06 | 8 | 148 | 3 | 2938743 | ||
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 16525059 | ||
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 18821566 | ||
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 27059595 | ||
| Pubmed | Two-stage case-control association study of dopamine-related genes and migraine. | 6.23e-06 | 9 | 148 | 3 | 19772578 | |
| Pubmed | 8.87e-06 | 10 | 148 | 3 | 21083670 | ||
| Pubmed | An essential role in liver development for transcription factor XBP-1. | 8.87e-06 | 10 | 148 | 3 | 10652269 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TMED1 MIA3 ARSK FOLR1 PROCR PIEZO1 MARCHF6 NAGA CAV1 APP TMEM87A MRPS22 LOX JMJD8 PGAP1 CDIPT TWSG1 | 1.52e-05 | 1201 | 148 | 17 | 35696571 |
| Pubmed | Collagen XIV is important for growth and structural integrity of the myocardium. | 1.62e-05 | 12 | 148 | 3 | 22906538 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15253437 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16216913 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12834818 | ||
| Pubmed | Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants. | 1.80e-05 | 2 | 148 | 2 | 16290938 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22970199 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24120383 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20970071 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18547596 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27349735 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15157739 | ||
| Pubmed | Orosomucoid-1 Arises as a Shared Altered Protein in Two Models of Multiple Sclerosis. | 1.80e-05 | 2 | 148 | 2 | 37949310 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11567069 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 10753124 | ||
| Pubmed | When chocolate seeking becomes compulsion: gene-environment interplay. | 1.80e-05 | 2 | 148 | 2 | 25781028 | |
| Pubmed | Comparison of alpha-1-acid glycoprotein isoforms from healthy and cancer patients by capillary IEF. | 1.80e-05 | 2 | 148 | 2 | 17987628 | |
| Pubmed | Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD. | 1.80e-05 | 2 | 148 | 2 | 11425949 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20188195 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22100647 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 26817615 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20081237 | ||
| Pubmed | Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes. | 1.80e-05 | 2 | 148 | 2 | 28927749 | |
| Pubmed | Distinct functions of the two isoforms of dopamine D2 receptors. | 1.80e-05 | 2 | 148 | 2 | 11089973 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31538542 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 26494566 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 34884474 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 33380525 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22415874 | ||
| Interaction | HRH3 interactions | 2.54e-06 | 5 | 129 | 3 | int:HRH3 | |
| Interaction | FCGR3A interactions | 5.47e-06 | 40 | 129 | 5 | int:FCGR3A | |
| Interaction | NCS1 interactions | 1.25e-05 | 80 | 129 | 6 | int:NCS1 | |
| Interaction | TTYH1 interactions | DRD2 MIA3 TPCN2 PIEZO1 TMC6 TMEM87A PIGQ SLC9A1 ATP8A1 PGAP1 | 2.38e-05 | 300 | 129 | 10 | int:TTYH1 |
| Cytoband | 22q11.2 | IGLV10-54 IGLV9-49 IGLV6-57 IGLV5-39 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 | 6.26e-15 | 120 | 148 | 12 | 22q11.2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | IGLV10-54 IGLV9-49 IGLV6-57 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 XKR3 | 1.36e-08 | 419 | 148 | 12 | chr22q11 |
| Cytoband | 7p14 | 4.34e-08 | 30 | 148 | 5 | 7p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 9.80e-05 | 226 | 148 | 6 | chr1q23 | |
| Cytoband | 17q25.1 | 1.42e-04 | 81 | 148 | 4 | 17q25.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p14 | 2.64e-04 | 174 | 148 | 5 | chr7p14 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | IGLV10-54 IGLV9-49 IGLV6-57 IGLV5-39 IGLV5-37 IGLV4-69 IGLV3-22 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 | 3.84e-13 | 89 | 115 | 12 | 353 |
| GeneFamily | T cell receptor gamma locus at 7p14 | 2.30e-07 | 22 | 115 | 5 | 375 | |
| GeneFamily | Dopamine receptors | 2.48e-06 | 5 | 115 | 3 | 181 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | CD248 PROCR ITGA2B FAS CD300C CD1B FCGR3A FCGR3B FCRL5 CDH1 IL2RB | 4.29e-05 | 394 | 115 | 11 | 471 |
| GeneFamily | Solute carriers | SLC10A4 SLC17A4 SLC10A3 SLC6A7 SLC9A1 SLC13A1 SLC20A2 SLC7A10 SLC4A9 SLC4A11 | 2.15e-04 | 395 | 115 | 10 | 752 |
| GeneFamily | Kallikreins | 4.54e-03 | 16 | 115 | 2 | 616 | |
| GeneFamily | Cystatins, type 2 | 4.54e-03 | 16 | 115 | 2 | 965 | |
| GeneFamily | Sulfatases | 5.74e-03 | 18 | 115 | 2 | 410 | |
| GeneFamily | Lipocalins | 6.39e-03 | 19 | 115 | 2 | 631 | |
| Coexpression | MARTENS_TRETINOIN_RESPONSE_UP | CYP4F8 DRD2 KLK10 CD248 F2RL3 GDF15 CST9 REG3G OTOP3 SLC6A7 TAS2R1 LRRN2 GRIN3B IL2RB SLC4A9 ITPRIPL1 HRH3 | 4.06e-06 | 855 | 142 | 17 | M2098 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2 | KLK10 CDHR2 GDF15 REG3G IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 CDH1 IGKV3-20 | 6.13e-06 | 266 | 131 | 10 | Arv_SC-hpx_blastocyst_1000_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5 | CDHR2 REG3G IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 IGKV3-20 | 1.83e-05 | 183 | 131 | 8 | Arv_SC_fibroblast_1000_K5 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3 | CDHR2 REG3G IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 IGKV3-20 | 1.83e-05 | 183 | 131 | 8 | Arv_SC-HD_1000_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | KLK10 CDHR2 ADGRB1 REG3G CA14 IGLV4-69 ORM2 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 KRTCAP3 IGKV3D-20 CCL19 KLK13 CDH1 IGKV3-20 HRH3 | 3.60e-05 | 986 | 131 | 18 | Arv_SC_fibroblast_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000 | KLK10 CDHR2 ADGRB1 REG3G CA14 IGLV4-69 ORM2 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 KRTCAP3 IGKV3D-20 CCL19 KLK13 CDH1 IGKV3-20 HRH3 | 3.60e-05 | 986 | 131 | 18 | Arv_SC-HD_1000 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CAV1 IGLV10-54 IGLV6-57 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 2.15e-11 | 179 | 147 | 11 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | CAV1 IGLV6-57 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 4.10e-10 | 177 | 147 | 10 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | CAV1 IGLV6-57 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 4.10e-10 | 177 | 147 | 10 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | CAV1 IGLV6-57 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 4.10e-10 | 177 | 147 | 10 | fc40918825b7e1eb6861df59dfca944778a64b98 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CAV1 IGLV6-57 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 4.58e-10 | 179 | 147 | 10 | 837ed81f18257f444eaeadc4fac89deedd4e3061 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CAV1 IGLV6-57 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 4.58e-10 | 179 | 147 | 10 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGLV10-54 IGLV6-57 IGLV5-37 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 9.53e-10 | 193 | 147 | 10 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | IGLV10-54 IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 3.11e-09 | 159 | 147 | 9 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | IGLV9-49 IGLV6-57 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 4.78e-09 | 167 | 147 | 9 | f2185eb72f0137136f6d71af2a70168fded6c940 |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | IGLV9-49 IGLV6-57 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 4.78e-09 | 167 | 147 | 9 | 5e768cf24699893e05d1bcb1c92dba2336943a64 |
| ToppCell | 10x5'-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | SGCA IGLV9-49 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 LRRN2 FCRL5 CNR2 | 6.19e-09 | 172 | 147 | 9 | 2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53 |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | CAV1 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 7.56e-09 | 176 | 147 | 9 | 4b4416f342b732d2cc60133838728880326257d8 |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | CAV1 IGLV2-33 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 7.56e-09 | 176 | 147 | 9 | d895a6b295cd649273ff80ad7785a3e0ae4c728a |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV9-49 IGLV6-57 IGLV4-69 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 FCRL5 IGKV3-20 | 9.20e-09 | 180 | 147 | 9 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGLV9-49 IGLV6-57 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.06e-08 | 183 | 147 | 9 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 |
| ToppCell | Control-Lymphocyte-B-B_memory|Control / Disease, Lineage and Cell Type | IGLV9-49 IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 EBI3 FCRL5 IGKV3-20 CNR2 | 1.06e-08 | 183 | 147 | 9 | 491fa04a1d2caeeec6c6403c9a38b4a1257fc2bc |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV9-49 IGLV6-57 IGLV4-69 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 FCRL5 IGKV3-20 | 1.11e-08 | 184 | 147 | 9 | 15f2c10101ccc8ed059520fc082ee42593dff269 |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV9-49 IGLV6-57 IGLV4-69 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 FCRL5 IGKV3-20 | 1.11e-08 | 184 | 147 | 9 | a90a58d9e319afa1cd572e4c2f516fadc42f56e5 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGLV10-54 IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.47e-08 | 190 | 147 | 9 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGLV10-54 IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.47e-08 | 190 | 147 | 9 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | TRGV5 IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.54e-08 | 191 | 147 | 9 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | IGLV6-57 IGLV5-37 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.61e-08 | 192 | 147 | 9 | 3dddfc93c3c954c4416c7c1f1f161e4d1dcc1233 |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | IGLV9-49 IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.93e-08 | 196 | 147 | 9 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGLV6-57 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 CNR2 | 2.01e-08 | 197 | 147 | 9 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c |
| ToppCell | Caecum-T_cell-CD8_T|T_cell / Region, Cell class and subclass | CD248 FCRL6 IGLV2-14 IGLV2-11 IGLV2-8 ATP8A1 FCGR3A FCRL5 IGKV3-20 | 2.29e-08 | 200 | 147 | 9 | 40e435f5dd1a0f6554f87dc1e170a740fd733d5b |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | IGLV10-54 IGLV9-49 IGLV6-57 IGLV2-14 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 2.49e-08 | 142 | 147 | 8 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue | 5.17e-08 | 156 | 147 | 8 | 0ea6ca3f38109151a2a4fdf63a4f009929cdcc40 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGLV9-49 IGLV6-57 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 FCRL5 IGKV3-20 | 9.60e-08 | 169 | 147 | 8 | 0c2384f780ec25710ebb35c0b0df8f4afb53c9b1 |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass | IGLV9-49 IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 9.60e-08 | 169 | 147 | 8 | b36b7632ce55fc7b6b8b66020563d360b3de6fd7 |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV9-49 IGLV6-57 IGLV4-69 IGLV2-18 IGLV2-11 IGKV3D-20 FCRL5 IGKV3-20 | 1.15e-07 | 173 | 147 | 8 | 0ca2169a275404118038c0489a48062879488765 |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue | CAV1 IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.26e-07 | 175 | 147 | 8 | 51301f3f44d3e88397f367cedd1e2abaa2be4c6f |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | IGLV9-49 IGLV6-57 IGLV4-69 IGLV2-14 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.31e-07 | 176 | 147 | 8 | 50e207403d48ce1b55a78897adb5519a2430a626 |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | IGLV9-49 IGLV6-57 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.37e-07 | 177 | 147 | 8 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|normal_Lymph_Node / Location, Cell class and cell subclass | CAV1 IGLV6-57 IGLV5-37 IGLV4-69 IGLV2-14 IGLV2-11 FCRL5 IGKV3-20 | 1.63e-07 | 181 | 147 | 8 | 949ac3b60e7fb5968da4c4e872965fb4e10f4a35 |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-07 | 181 | 147 | 8 | 700adfb41e4e377530f0dd31be89e12f109f3469 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.77e-07 | 183 | 147 | 8 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | CAV1 IGLV9-49 IGLV6-57 IGLV2-14 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.84e-07 | 184 | 147 | 8 | 6f70d8f8ab8362d51f8a58735d42223e06566397 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGLV9-49 IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 FCRL5 IGKV3-20 | 1.92e-07 | 185 | 147 | 8 | 0fff2608f507e019ebb69c27e58fd5be3b049bef |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGLV9-49 IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 FCRL5 IGKV3-20 | 1.92e-07 | 185 | 147 | 8 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV6-57 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.92e-07 | 185 | 147 | 8 | 08bc817908076734d66f2805cb954141f2cc5a18 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV6-57 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 1.92e-07 | 185 | 147 | 8 | 1704a12153a9b107bf03ecccd1a036cf61334d7a |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | CAV1 IGLV10-54 IGLV2-18 IGLV2-14 IGLV2-11 IGKV3D-20 FCRL5 IGKV3-20 | 2.00e-07 | 186 | 147 | 8 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | CAV1 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 2.17e-07 | 188 | 147 | 8 | bd53b0371154cff680226897b61c9809a239d1b6 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV10-54 IGLV9-49 IGLV6-57 IGLV5-37 IGLV2-14 IGKV3D-20 FCRL5 IGKV3-20 | 2.17e-07 | 188 | 147 | 8 | 6844cebca177fdf38b21a40d606230a033717a3a |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | CAV1 IGLV6-57 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 FCRL5 IGKV3-20 | 2.36e-07 | 190 | 147 | 8 | 1f907016980ccfbf089e354d91d931771e8a83e0 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGLV10-54 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 FCRL5 IGKV3-20 CNR2 | 2.45e-07 | 191 | 147 | 8 | 8c35fccc4617694eae1e55b1107841ffe7f1bac8 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGLV10-54 IGLV6-57 IGLV4-69 IGLV2-14 IGLV2-11 FCRL5 IGKV3-20 CNR2 | 2.66e-07 | 193 | 147 | 8 | e9bbc2c4516341524686aa095aae4ae7e80a688a |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 2.76e-07 | 194 | 147 | 8 | a4a70369541876e1192df8828b63e3d1746ae3d9 |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 2.99e-07 | 196 | 147 | 8 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | IGLV6-57 IGLV5-37 IGLV2-18 IGLV2-14 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 2.99e-07 | 196 | 147 | 8 | b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGKV3D-20 FCRL5 IGKV3-20 CNR2 | 3.10e-07 | 197 | 147 | 8 | 2662138671262b30508c5759038bcdcfe6551696 |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue | 3.10e-07 | 197 | 147 | 8 | 13e6611cde9364f0c1bf681b0b26c4d2725e5f4a | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 3.10e-07 | 197 | 147 | 8 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | CAV1 IGLV4-69 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 3.35e-07 | 199 | 147 | 8 | c11aa8bca3723a886e7082ae48bb922dd8396be4 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Unfolded_protein_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-07 | 200 | 147 | 8 | 12078bc25be67180c0f4b37fef921cdcd1003576 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Plasma_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.06e-07 | 94 | 147 | 6 | 4b6623de5a517ebf5df865e0dcd615111622ad3e | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.49e-07 | 152 | 147 | 7 | a2ba2d95ac9010e1a62db34dcad10d004f8a90cc | |
| ToppCell | Mild-Lymphoid-Plasma|Mild / Condition, Lineage, Cell class and cell subclass | 1.06e-06 | 160 | 147 | 7 | 7fdb849f5caf5a127a2582326215e11f8eb4fa0e | |
| ToppCell | Mild-Lymphoid-Plasma-|Mild / Condition, Lineage, Cell class and cell subclass | 1.06e-06 | 160 | 147 | 7 | aa79848913910c01249d6cacf4ed53ec0e4f5c3d | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.20e-06 | 163 | 147 | 7 | ec8336b68c8369e27d507c04c827be07bb48a7f6 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGLV6-57 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IGKV3D-20 IGKV3-20 | 1.35e-06 | 166 | 147 | 7 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | IGLV6-57 IGLV2-33 IGLV2-18 IGLV2-11 IGLV2-8 IGKV3D-20 IGKV3-20 | 1.47e-06 | 168 | 147 | 7 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-06 | 169 | 147 | 7 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-06 | 172 | 147 | 7 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-06 | 172 | 147 | 7 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-06 | 172 | 147 | 7 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-06 | 176 | 147 | 7 | 8b5c2fb7e5e551df658b1d5fc7f607a27bab00d5 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-06 | 177 | 147 | 7 | 709235694cc711b9b79690e23c94577b2ae06811 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-06 | 177 | 147 | 7 | 7f9c2a45a994b32f15e5693f7cb873716a4eb568 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-06 | 178 | 147 | 7 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.32e-06 | 180 | 147 | 7 | e3877f6ef5f54ff689058b4c996ab1851822f871 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV6-57 IGLV4-69 IGLV2-14 IGLV2-11 IGKV3D-20 FCRL5 IGKV3-20 | 2.41e-06 | 181 | 147 | 7 | e47664a264a2c37390d1668ce04eef2e0172f4cb |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-06 | 182 | 147 | 7 | 1bf2e4fd6222b41a7d08df6dcc500c9401db8c18 | |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | 2.59e-06 | 183 | 147 | 7 | 9b64d2d143525e6f48a191facfd101462ff36324 | |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | 2.59e-06 | 183 | 147 | 7 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.68e-06 | 184 | 147 | 7 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.68e-06 | 184 | 147 | 7 | 64bede8db709fd32f40c03265b96f0b12155bb8a | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-MALT_B_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.78e-06 | 185 | 147 | 7 | bb87fa174f80706fe7be60d3b9fc3e2a6b373038 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.78e-06 | 185 | 147 | 7 | 609080adb2cfb105bb7b8efb617553833299f371 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV10-54 IGLV6-57 IGLV2-14 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 2.78e-06 | 185 | 147 | 7 | 6ec009e48e50471c28e914c402f500e56a88f8f2 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV10-54 IGLV6-57 IGLV2-14 IGLV2-8 IGKV3D-20 FCRL5 IGKV3-20 | 2.78e-06 | 185 | 147 | 7 | f49ad6401b2abd089e30eba245b11b5031ea2318 |
| ToppCell | metastatic_Brain-B_lymphocytes|metastatic_Brain / Location, Cell class and cell subclass | 2.78e-06 | 185 | 147 | 7 | 153b82dc5ace03f84dc82d724d56bdc93aa020df | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma|Liver / Manually curated celltypes from each tissue | 2.88e-06 | 186 | 147 | 7 | a2c7430781f432c9c90ac4d620f4518ff767a223 | |
| ToppCell | Mild-Lymphoid-T-NK|Mild / Condition, Lineage, Cell class and cell subclass | 2.88e-06 | 186 | 147 | 7 | ed37a2df547661d22c1ed0b30cb1c19e489d9d0a | |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.88e-06 | 186 | 147 | 7 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 | |
| ToppCell | control-Lymphocytic-Plasmablast|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.99e-06 | 187 | 147 | 7 | 94a44b31ce9fe6fb4758769018fb746e93c8f043 | |
| ToppCell | cellseq2-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.09e-06 | 188 | 147 | 7 | 33360f1c30315d9772731c9067834dc059172b79 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.20e-06 | 189 | 147 | 7 | 5a42be62552d912d0abf68f00d75ac80bbd69f2c | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue | 3.20e-06 | 189 | 147 | 7 | e8ff2c4fd2481bfbc99a5a6f02e0db8c995b3a23 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.32e-06 | 190 | 147 | 7 | a21d0c574abf21e7cb865a21a48f29c92d055fbe | |
| ToppCell | Club|World / shred by cell class for parenchyma | 3.32e-06 | 190 | 147 | 7 | 1974d559d7fee6cb68065b18af8bd38b64910622 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.43e-06 | 191 | 147 | 7 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue | 3.43e-06 | 191 | 147 | 7 | f802a4686ecf00e8302047bfe23356f24b266cf8 | |
| ToppCell | cellseq2-Immune-Lymphocytic_B-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.43e-06 | 191 | 147 | 7 | 17746a32f723c078aba1f7e320b0e3f1ab8bf5c6 | |
| ToppCell | cellseq2-Immune-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.43e-06 | 191 | 147 | 7 | c2c450df810f83163987cd0f7ed9b50025cd3de1 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 3.55e-06 | 192 | 147 | 7 | 4d72b9264ed62e0c08cde4078061b348253f6989 | |
| ToppCell | droplet-Lung-30m-Mesenchymal|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.55e-06 | 192 | 147 | 7 | 5d5bec238b196f0b3e727fd94f078d6ae524cb01 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-G_(Club-Clara_cells)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.55e-06 | 192 | 147 | 7 | c7c232545fad8ad327ab94bd0def8dc5daacd03d | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.55e-06 | 192 | 147 | 7 | ff4b728a55c2550c806c47e9ae3d057c35df8464 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.55e-06 | 192 | 147 | 7 | 2d3790bd80a7f214b37094121a2a86ff16362569 | |
| Computational | Genes in the cancer module 27. | DRD3 PGLYRP1 FOLR1 NTSR1 ITGA2B FAS CD300C GHR FCGR3A IL2RB HYAL2 CNR2 | 7.43e-06 | 355 | 77 | 12 | MODULE_27 |
| Computational | Membranal receptors. | DRD3 PGLYRP1 FOLR1 CAV1 ITGA2B FAS CD300C GHR SLC6A7 FCGR3A CCL19 CX3CL1 IL2RB CNR2 | 1.52e-05 | 517 | 77 | 14 | MODULE_64 |
| Computational | Genes in the cancer module 46. | PGLYRP1 FAS CD300C ORM1 ORM2 CD1B FCGR3A FCGR3B CCL19 CX3CL1 IL2RB CNR2 | 2.12e-05 | 394 | 77 | 12 | MODULE_46 |
| Computational | Immune response. | PGLYRP1 FAS CD300C ORM1 ORM2 FCGR3A FCGR3B CCL19 CX3CL1 IL2RB CNR2 | 1.16e-04 | 398 | 77 | 11 | MODULE_75 |
| Computational | Porins / transporters. | 7.64e-04 | 211 | 77 | 7 | MODULE_63 | |
| Computational | Neighborhood of IGF1 | 8.16e-04 | 26 | 77 | 3 | GNF2_IGF1 | |
| Drug | iodide | VLDLR DRD2 DRD3 CYP19A1 NTSR1 APCS ITGA2B SSTR5 GHR LHCGR SLC6A7 ORM1 ORM2 FCGR3A FCGR3B IL2RB SLC4A9 | 1.71e-08 | 534 | 134 | 17 | CID000024841 |
| Drug | quinagolide | 7.13e-08 | 19 | 134 | 5 | CID000055645 | |
| Drug | 6-Br-APB | 3.67e-07 | 11 | 134 | 4 | CID000005016 | |
| Drug | TAM67 | 1.49e-06 | 15 | 134 | 4 | CID000005626 | |
| Drug | lergotrile | 1.98e-06 | 16 | 134 | 4 | CID000037586 | |
| Drug | EMATE | 1.98e-06 | 16 | 134 | 4 | CID000127676 | |
| Drug | Haloperidol | 1.98e-06 | 5 | 134 | 3 | DB00502 | |
| Drug | tilozepine | 1.98e-06 | 5 | 134 | 3 | CID000172286 | |
| Drug | SKF 77434 | 1.98e-06 | 5 | 134 | 3 | CID000001241 | |
| Drug | Levodopa | 1.98e-06 | 5 | 134 | 3 | DB01235 | |
| Drug | dazopride | 1.98e-06 | 5 | 134 | 3 | CID000054801 | |
| Drug | azapride | 1.98e-06 | 5 | 134 | 3 | CID003036441 | |
| Drug | 2-di-n-propylaminoindan | 1.98e-06 | 5 | 134 | 3 | CID000130402 | |
| Drug | mezilamine | 1.98e-06 | 5 | 134 | 3 | CID000068678 | |
| Drug | NO 756 | 1.98e-06 | 5 | 134 | 3 | CID000129967 | |
| Drug | SKF85174 | 1.98e-06 | 5 | 134 | 3 | CID000132435 | |
| Drug | 3-iodobenzamide | 1.98e-06 | 5 | 134 | 3 | CID000202425 | |
| Drug | neurotensin 69L | 1.98e-06 | 5 | 134 | 3 | ctd:C407426 | |
| Drug | rotigotine | 1.98e-06 | 5 | 134 | 3 | ctd:C047508 | |
| Drug | piquindone | 1.98e-06 | 5 | 134 | 3 | CID000121903 | |
| Drug | triethylenephosphoramide | 2.31e-06 | 65 | 134 | 6 | CID000011016 | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; HL60; HT_HG-U133A | 2.83e-06 | 199 | 134 | 9 | 3089_UP | |
| Drug | SKF 82958 | 3.21e-06 | 39 | 134 | 5 | CID000001225 | |
| Drug | 7-OH-DPAT | 3.21e-06 | 39 | 134 | 5 | CID000001219 | |
| Drug | A66359 | 3.94e-06 | 6 | 134 | 3 | CID000173657 | |
| Drug | CI-943 | 3.94e-06 | 6 | 134 | 3 | CID000146009 | |
| Drug | propylbutyldopamine | 3.94e-06 | 6 | 134 | 3 | CID000156067 | |
| Drug | 7-hydroxyamoxapine | 3.94e-06 | 6 | 134 | 3 | CID000162242 | |
| Drug | BAM-1110 | 3.94e-06 | 6 | 134 | 3 | CID003064755 | |
| Drug | 2'-ISP | 3.94e-06 | 6 | 134 | 3 | CID000128389 | |
| Drug | Rotigotine | 3.94e-06 | 6 | 134 | 3 | DB05271 | |
| Drug | pergolide sulfone | 3.94e-06 | 6 | 134 | 3 | CID000155750 | |
| Drug | pergolide sulfoxide | 3.94e-06 | 6 | 134 | 3 | CID000155749 | |
| Drug | AC1L1JFX | 3.94e-06 | 6 | 134 | 3 | CID000005023 | |
| Drug | N,N-dimethyldopamine | 3.94e-06 | 6 | 134 | 3 | CID000152427 | |
| Drug | oxiperomide | 3.94e-06 | 6 | 134 | 3 | CID000068634 | |
| Drug | AC1L1I8U | 3.94e-06 | 6 | 134 | 3 | CID000055036 | |
| Drug | p-bromospiperone | 3.94e-06 | 6 | 134 | 3 | CID000156386 | |
| Drug | MDO-NPA | 3.94e-06 | 6 | 134 | 3 | CID000133642 | |
| Drug | LY293284 | 3.94e-06 | 6 | 134 | 3 | CID000132345 | |
| Drug | Phenethylamines | 3.94e-06 | 6 | 134 | 3 | ctd:D010627 | |
| Drug | furosemide | KLK10 APCS CA14 SLC10A3 ORM1 ORM2 SLC9A1 SLC20A2 KLK13 SLC4A9 | 4.99e-06 | 272 | 134 | 10 | CID000003440 |
| Drug | SKF 83566 | 5.17e-06 | 20 | 134 | 4 | CID000001243 | |
| Drug | AC1L9NGT | 6.86e-06 | 7 | 134 | 3 | CID000449733 | |
| Drug | N,N-dipropyl-5,6-ADTN | 6.86e-06 | 7 | 134 | 3 | CID000122167 | |
| Drug | UH 242 | 6.86e-06 | 7 | 134 | 3 | CID000125884 | |
| Drug | NCQ 298 | 6.86e-06 | 7 | 134 | 3 | CID000086228 | |
| Drug | flumezapine | 6.86e-06 | 7 | 134 | 3 | CID000043602 | |
| Drug | Dopamine | 6.86e-06 | 7 | 134 | 3 | DB00988 | |
| Drug | FLB 457 | 6.86e-06 | 7 | 134 | 3 | CID000129497 | |
| Drug | isofloxythepin | 6.86e-06 | 7 | 134 | 3 | CID000115193 | |
| Drug | FIDA2 | 6.86e-06 | 7 | 134 | 3 | CID000130295 | |
| Drug | 7-methyl-6,7,8,9,14,15-hexahydro-5H-benz(d)indolo(2,3-g)azecine | 6.86e-06 | 7 | 134 | 3 | ctd:C409874 | |
| Drug | perazine | 9.31e-06 | 23 | 134 | 4 | CID000004744 | |
| Drug | Cabergoline-d5 | 9.67e-06 | 83 | 134 | 6 | CID000002512 | |
| Drug | AC1L1C1F | 1.01e-05 | 49 | 134 | 5 | CID000001699 | |
| Drug | DP-8OH-3CA | 1.09e-05 | 8 | 134 | 3 | CID000086131 | |
| Drug | 5-methoxy-1-methyl-2-(n-propylamino)tetralin | 1.09e-05 | 8 | 134 | 3 | CID000122334 | |
| Drug | AC1L1F9K | 1.09e-05 | 8 | 134 | 3 | CID000003142 | |
| Drug | UH232 | 1.09e-05 | 8 | 134 | 3 | CID005311190 | |
| Drug | alizapride | 1.09e-05 | 8 | 134 | 3 | CID000043008 | |
| Drug | Sch 23982 | 1.09e-05 | 8 | 134 | 3 | CID000119353 | |
| Drug | BW 737C | 1.09e-05 | 8 | 134 | 3 | CID000132241 | |
| Drug | beta-CIT | 1.11e-05 | 24 | 134 | 4 | CID000108220 | |
| Drug | clonidine | 1.29e-05 | 240 | 134 | 9 | CID000002803 | |
| Drug | T15550 | 1.55e-05 | 26 | 134 | 4 | CID000005454 | |
| Drug | 3',4'-dihydroxynomifensine | 1.63e-05 | 9 | 134 | 3 | CID000194310 | |
| Drug | CQ 32-084 | 1.63e-05 | 9 | 134 | 3 | CID000068847 | |
| Drug | 11-OH-NPa | 1.63e-05 | 9 | 134 | 3 | CID000127708 | |
| Drug | NIASP | 1.63e-05 | 9 | 134 | 3 | CID006439184 | |
| Drug | halopemide | 1.63e-05 | 9 | 134 | 3 | CID000065490 | |
| Drug | CTK4D3724 | 1.63e-05 | 9 | 134 | 3 | CID000128010 | |
| Drug | PAOPA | 1.63e-05 | 9 | 134 | 3 | CID000129409 | |
| Drug | [11c]tmsx | 1.63e-05 | 9 | 134 | 3 | CID005461878 | |
| Drug | 1 msn | 1.63e-05 | 9 | 134 | 3 | CID000446837 | |
| Drug | AC1OCEMN | 1.63e-05 | 9 | 134 | 3 | CID006917765 | |
| Drug | U91356A | 1.63e-05 | 9 | 134 | 3 | CID000132955 | |
| Drug | aminoindole | 1.64e-05 | 54 | 134 | 5 | CID000122074 | |
| Drug | Rds-127 | 2.32e-05 | 10 | 134 | 3 | CID000134064 | |
| Drug | 5-OH-DPAT | 2.32e-05 | 10 | 134 | 3 | CID000172267 | |
| Drug | clebopride | 2.32e-05 | 10 | 134 | 3 | CID000002780 | |
| Drug | cyclo(Leu-Gly) | 2.32e-05 | 10 | 134 | 3 | CID000002902 | |
| Drug | 2-(di-n-propylamino)tetralin | 2.32e-05 | 10 | 134 | 3 | CID000090285 | |
| Drug | U-86170F | 2.32e-05 | 10 | 134 | 3 | CID000131559 | |
| Drug | SDZ 208-912 | 2.32e-05 | 10 | 134 | 3 | CID000058145 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 2.32e-05 | 198 | 134 | 8 | 3710_UP | |
| Drug | ergocryptine | 2.43e-05 | 29 | 134 | 4 | CID000099049 | |
| Drug | methadone | 2.76e-05 | 60 | 134 | 5 | CID000004095 | |
| Drug | sultopride | 3.18e-05 | 11 | 134 | 3 | CID000005357 | |
| Drug | NNC 112 | 3.18e-05 | 11 | 134 | 3 | CID000130424 | |
| Drug | AC1L1CM5 | 3.18e-05 | 11 | 134 | 3 | CID000001961 | |
| Drug | N-methylspiperone | 3.18e-05 | 11 | 134 | 3 | CID000119146 | |
| Drug | Sulpiride | 3.44e-05 | 2 | 134 | 2 | DB00391 | |
| Drug | N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride | 3.44e-05 | 2 | 134 | 2 | ctd:C016868 | |
| Drug | 5-methoxy-1-methyl-2-(n-propylamino)tetralin | 3.44e-05 | 2 | 134 | 2 | ctd:C051171 | |
| Drug | CGS 15855A | 3.44e-05 | 2 | 134 | 2 | ctd:C051347 | |
| Drug | 1-(4-chlorobenzoyl)-5-methoxy-1H-indole-3-acetic acid morpholineamide | 3.44e-05 | 2 | 134 | 2 | ctd:C558917 | |
| Drug | (5,6-dimethoxyindan-2-yl)dipropylamine | 3.44e-05 | 2 | 134 | 2 | ctd:C086335 | |
| Drug | Domperidone | 3.44e-05 | 2 | 134 | 2 | DB01184 | |
| Drug | norlorcainide | 3.44e-05 | 2 | 134 | 2 | CID000162188 | |
| Disease | heroin dependence (biomarker_via_orthology) | 1.63e-09 | 5 | 127 | 4 | DOID:9976 (biomarker_via_orthology) | |
| Disease | Etat Marbre | 2.72e-06 | 23 | 127 | 4 | C0266487 | |
| Disease | Recurrent depression | 6.42e-06 | 9 | 127 | 3 | C0221480 | |
| Disease | Movement Disorders | 7.15e-06 | 29 | 127 | 4 | C0026650 | |
| Disease | Lenticulostriate Disorders | 1.67e-05 | 12 | 127 | 3 | C0750951 | |
| Disease | Extrapyramidal Disorders | 1.67e-05 | 12 | 127 | 3 | C0015371 | |
| Disease | Basal Ganglia Diseases | 1.67e-05 | 12 | 127 | 3 | C0004782 | |
| Disease | level of low affinity immunoglobulin gamma Fc region receptor III-A in blood serum | 1.84e-05 | 2 | 127 | 2 | OBA_2040305 | |
| Disease | Dyskinesia, Medication-Induced | 3.41e-05 | 15 | 127 | 3 | C0751088 | |
| Disease | Dyskinesia, Drug-Induced | 3.41e-05 | 15 | 127 | 3 | C0013386 | |
| Disease | dermatomyositis (is_marker_for) | 5.07e-05 | 17 | 127 | 3 | DOID:10223 (is_marker_for) | |
| Disease | Lupus Vasculitis, Central Nervous System | 5.50e-05 | 3 | 127 | 2 | C0752332 | |
| Disease | Lupus Meningoencephalitis | 5.50e-05 | 3 | 127 | 2 | C0752334 | |
| Disease | Neuropsychiatric Systemic Lupus Erythematosus | 5.50e-05 | 3 | 127 | 2 | C0752335 | |
| Disease | Disruptive, Impulse Control, and Conduct Disorders | 5.50e-05 | 3 | 127 | 2 | C0021122 | |
| Disease | Intermittent Explosive Disorder | 5.50e-05 | 3 | 127 | 2 | C0021776 | |
| Disease | Coronary Arteriosclerosis | 1.81e-04 | 65 | 127 | 4 | C0010054 | |
| Disease | Coronary Artery Disease | 1.81e-04 | 65 | 127 | 4 | C1956346 | |
| Disease | acute pancreatitis (implicated_via_orthology) | 1.82e-04 | 5 | 127 | 2 | DOID:2913 (implicated_via_orthology) | |
| Disease | serine protease inhibitor Kazal-type 2 measurement | 2.73e-04 | 6 | 127 | 2 | EFO_0802054 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 2.90e-04 | 30 | 127 | 3 | DOID:14330 (biomarker_via_orthology) | |
| Disease | Hyperkinesia | 3.53e-04 | 32 | 127 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 3.53e-04 | 32 | 127 | 3 | C0751217 | |
| Disease | Seizures | 3.73e-04 | 218 | 127 | 6 | C0036572 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 3.81e-04 | 7 | 127 | 2 | EFO_0008211 | |
| Disease | breast cancer (is_implicated_in) | 4.91e-04 | 150 | 127 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | sickle cell anemia | 5.06e-04 | 8 | 127 | 2 | MONDO_0011382 | |
| Disease | Cognition Disorders | 5.88e-04 | 38 | 127 | 3 | C0009241 | |
| Disease | kallikrein-11 measurement | 6.49e-04 | 9 | 127 | 2 | EFO_0010573 | |
| Disease | amnestic disorder (implicated_via_orthology) | 6.49e-04 | 9 | 127 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | plexin-B2 measurement | 6.49e-04 | 9 | 127 | 2 | EFO_0021867 | |
| Disease | Malignant neoplasm of breast | TMED1 KLK10 CYP19A1 APCS COLGALT2 CAV1 MRPS22 LHCGR FCRL5 GALNT5 HERC2 CDH1 CNR2 | 7.55e-04 | 1074 | 127 | 13 | C0006142 |
| Disease | Delirium | 8.09e-04 | 10 | 127 | 2 | C0011206 | |
| Disease | Memory Loss | 8.47e-04 | 43 | 127 | 3 | C0751295 | |
| Disease | Age-Related Memory Disorders | 8.47e-04 | 43 | 127 | 3 | C0751292 | |
| Disease | Memory Disorder, Spatial | 8.47e-04 | 43 | 127 | 3 | C0751294 | |
| Disease | Memory Disorder, Semantic | 8.47e-04 | 43 | 127 | 3 | C0751293 | |
| Disease | Memory Disorders | 8.47e-04 | 43 | 127 | 3 | C0025261 | |
| Disease | Alzheimer's disease (is_marker_for) | 8.84e-04 | 257 | 127 | 6 | DOID:10652 (is_marker_for) | |
| Disease | Memory impairment | 9.06e-04 | 44 | 127 | 3 | C0233794 | |
| Disease | polymyositis (is_marker_for) | 9.86e-04 | 11 | 127 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | pigmentation disease (is_implicated_in) | 9.86e-04 | 11 | 127 | 2 | DOID:10123 (is_implicated_in) | |
| Disease | coagulation factor XA measurement | 9.86e-04 | 11 | 127 | 2 | EFO_0020266 | |
| Disease | pars orbitalis volume measurement | 9.86e-04 | 11 | 127 | 2 | EFO_0010320 | |
| Disease | visual epilepsy (is_implicated_in) | 9.86e-04 | 11 | 127 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | Weight Gain | 1.00e-03 | 102 | 127 | 4 | C0043094 | |
| Disease | Alcoholic Intoxication, Chronic | 1.10e-03 | 268 | 127 | 6 | C0001973 | |
| Disease | Bipolar Disorder | 1.10e-03 | 477 | 127 | 8 | C0005586 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.18e-03 | 12 | 127 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Pain, Migratory | 1.24e-03 | 49 | 127 | 3 | C0751407 | |
| Disease | Suffering, Physical | 1.24e-03 | 49 | 127 | 3 | C0751408 | |
| Disease | Pain, Crushing | 1.24e-03 | 49 | 127 | 3 | C0458259 | |
| Disease | Pain, Splitting | 1.24e-03 | 49 | 127 | 3 | C0458257 | |
| Disease | Pain | 1.24e-03 | 49 | 127 | 3 | C0030193 | |
| Disease | Radiating pain | 1.24e-03 | 49 | 127 | 3 | C0234254 | |
| Disease | Pain, Burning | 1.24e-03 | 49 | 127 | 3 | C0234230 | |
| Disease | Ache | 1.24e-03 | 49 | 127 | 3 | C0234238 | |
| Disease | Streptozotocin Diabetes | 1.24e-03 | 108 | 127 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 1.24e-03 | 108 | 127 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 1.24e-03 | 108 | 127 | 4 | C0002152 | |
| Disease | coagulation factor X measurement | 1.39e-03 | 13 | 127 | 2 | EFO_0020265 | |
| Disease | Schizophrenia | VLDLR DRD1 DRD2 DRD3 ADAMTS3 NTSR1 CAV1 FAS HHAT SLC7A10 CNR2 | 1.55e-03 | 883 | 127 | 11 | C0036341 |
| Disease | low affinity immunoglobulin gamma Fc region receptor III-B measurement | 1.62e-03 | 14 | 127 | 2 | EFO_0008212 | |
| Disease | Pneumonia | 1.65e-03 | 54 | 127 | 3 | C0032285 | |
| Disease | Lobar Pneumonia | 1.65e-03 | 54 | 127 | 3 | C0032300 | |
| Disease | Pneumonitis | 1.65e-03 | 54 | 127 | 3 | C3714636 | |
| Disease | Experimental Lung Inflammation | 1.65e-03 | 54 | 127 | 3 | C0887898 | |
| Disease | prostate cancer (is_implicated_in) | 1.67e-03 | 117 | 127 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | Waxy flexibility | 1.86e-03 | 15 | 127 | 2 | C0233612 | |
| Disease | Catalepsy | 1.86e-03 | 15 | 127 | 2 | C0007370 | |
| Disease | hepatoblastoma (is_marker_for) | 1.86e-03 | 15 | 127 | 2 | DOID:687 (is_marker_for) | |
| Disease | anemia (implicated_via_orthology) | 1.86e-03 | 15 | 127 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | 1.94e-03 | 774 | 127 | 10 | C0023893 | |
| Disease | developmental dysplasia of the hip | 2.12e-03 | 16 | 127 | 2 | EFO_1000648 | |
| Disease | Tactile Amnesia | 2.40e-03 | 17 | 127 | 2 | C0750906 | |
| Disease | Amnestic State | 2.40e-03 | 17 | 127 | 2 | C0750907 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 2.40e-03 | 17 | 127 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | Dissociative Amnesia | 2.40e-03 | 17 | 127 | 2 | C0236795 | |
| Disease | Hysterical amnesia | 2.40e-03 | 17 | 127 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 2.40e-03 | 17 | 127 | 2 | C0233796 | |
| Disease | Keloid | 2.40e-03 | 17 | 127 | 2 | EFO_0004212 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 2.40e-03 | 17 | 127 | 2 | EFO_0021969 | |
| Disease | Amnesia | 2.40e-03 | 17 | 127 | 2 | C0002622 | |
| Disease | Global Amnesia | 2.40e-03 | 17 | 127 | 2 | C0262497 | |
| Disease | cutaneous melanoma, hair color | 2.45e-03 | 62 | 127 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | Allergic Reaction | 2.56e-03 | 63 | 127 | 3 | C1527304 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.59e-03 | 132 | 127 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | Hypersensitivity | 2.68e-03 | 64 | 127 | 3 | C0020517 | |
| Disease | ovarian neoplasm | 2.73e-03 | 134 | 127 | 4 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 2.96e-03 | 137 | 127 | 4 | C1140680 | |
| Disease | Alcohol abuse | 3.05e-03 | 67 | 127 | 3 | C0085762 | |
| Disease | Parkinson's disease (is_marker_for) | 3.05e-03 | 67 | 127 | 3 | DOID:14330 (is_marker_for) | |
| Disease | rheumatoid arthritis (is_marker_for) | 3.32e-03 | 69 | 127 | 3 | DOID:7148 (is_marker_for) | |
| Disease | atherosclerosis (biomarker_via_orthology) | 3.32e-03 | 20 | 127 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | end stage renal disease (implicated_via_orthology) | 3.32e-03 | 20 | 127 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | hepatitis B (is_marker_for) | 3.66e-03 | 21 | 127 | 2 | DOID:2043 (is_marker_for) | |
| Disease | Splenomegaly | 4.01e-03 | 22 | 127 | 2 | C0038002 | |
| Disease | Amphetamine-Related Disorders | 4.20e-03 | 75 | 127 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 4.20e-03 | 75 | 127 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 4.20e-03 | 75 | 127 | 3 | C0236804 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LAILMFLTWLPESLS | 11 | Q9GZX9 | |
| MLLLWVSVVAALALA | 1 | Q6UWY0 | |
| MTSSLKIWGILLALL | 1 | Q14507 | |
| MLTTLLPILLLSGWA | 1 | Q9UNN8 | |
| VAVLMLLTSALGLPW | 761 | Q96Q91 | |
| FRSWLPAMLAVLLSL | 11 | P51690 | |
| MLPGLALLLLAAWTA | 1 | P05067 | |
| LLLWSAVLIMYPTSL | 121 | Q9NS82 | |
| VVLPLLALTWMSAVL | 1141 | O14514 | |
| MLLRLLLAWAAAGPT | 1 | Q9HCU0 | |
| MALSWVLTVLSLLPL | 1 | P19652 | |
| MAASWSLLVTLRPLA | 1 | Q8WV93 | |
| LAVSDLLVAVLVMPW | 66 | P21728 | |
| LFRMGLWVTAPIALL | 171 | O14735 | |
| PSLLLLLCLALWYMR | 311 | P29016 | |
| RLLSALFGIPMALIW | 101 | Q03135 | |
| PWALSLLLMGFQLLV | 11 | Q5W186 | |
| FWMGLLFIPVASLLL | 1051 | Q9Y2Q0 | |
| ELPLLLSMLGAVLWV | 191 | Q08708 | |
| LAVLLICWFPVLALM | 251 | P34972 | |
| GQPLLLSLLILAMWV | 11 | Q9Y5H5 | |
| SWLVSFLIIFPALML | 146 | Q96RD1 | |
| MAWTPLLFLTLLLHC | 1 | A0A075B6H9 | |
| MWPLALVIASLTLAL | 1 | Q9UKR3 | |
| LLALVLMPLCLWIYS | 206 | Q96EP9 | |
| MWLPALVLATLAASA | 1 | Q9UKY3 | |
| MAWTPLLLLLLSHCT | 1 | A0A075B6J1 | |
| GLMLTLATNLLLWVL | 231 | Q7RTS5 | |
| LALVLAVSWAMELKP | 11 | Q12891 | |
| MRLPKLLTFLLWYLA | 1 | P43026 | |
| MLALSWALALGLVLL | 161 | Q9GZN0 | |
| WLFSSLIAMLPLVGV | 491 | P22888 | |
| PWNLILLTVFTLSMA | 166 | Q9BWQ8 | |
| METPAQLLFLLLLWL | 1 | A0A0C4DH25 | |
| MAWTPLLLLLLSHCT | 1 | A0A0G2JS06 | |
| MAWALLLLTLLTQGT | 1 | A0A075B6J2 | |
| AIWLASALLAVPMLF | 191 | P30989 | |
| MLPLWTLSLLLGAVA | 1 | P16233 | |
| MLSAILLLLQLWDSG | 306 | O95714 | |
| MRLLVAPLLLAWVAG | 1 | O75325 | |
| MALLLALSLLVLWTS | 1 | Q99731 | |
| WVTLLSMVLGSLLAL | 26 | Q9BVA6 | |
| WLPASLLGLMVIAAA | 311 | Q6DN72 | |
| MAWAPLLLTLLAHCT | 1 | P01721 | |
| MLLWVILLVLAPVSG | 1 | Q96RD9 | |
| MAWAPLLLTLLSLLT | 1 | A0A0B4J1Y8 | |
| RSFWMTLLTDALPLL | 571 | Q9BW27 | |
| MLAASIFRPTLLLCW | 1 | Q8N119 | |
| LALTTMPTVLGVLWL | 71 | Q9H339 | |
| SLSTLPTMLAVLWLD | 76 | Q8NGJ5 | |
| LSMLRAALLLISLPW | 26 | P09131 | |
| MLLAWALPSLLRLGA | 6 | O75594 | |
| VFGSIVLLMLWLPIR | 486 | O60337 | |
| MAWALLLLTLLTQGT | 1 | A0A075B6J9 | |
| GSQMLLVLLVLSWLP | 11 | Q99988 | |
| MWLAAAAPSLARRLL | 1 | A6NEC2 | |
| MLLSIAIISALLWLP | 251 | Q8TDV0 | |
| MPWTILLFAAGSLAI | 1 | A8MVS5 | |
| WLMAAALALPLTLQR | 201 | Q96RI0 | |
| LITSTAVPFMLWGLL | 71 | Q8NGU1 | |
| MLPRWELALYLLASL | 1 | Q5VTY9 | |
| MAWATLLLPLLNLYT | 1 | A0A075B6J6 | |
| LLAIMLSATLTIPIW | 346 | Q8NA29 | |
| MWSLLLCGLSIALPL | 1 | Q9HB29 | |
| TALMHLLLRLPLTDW | 451 | Q6GPH6 | |
| LLLRLPLTDWAHNML | 456 | Q6GPH6 | |
| MVLLSLWLIAAALVE | 1 | O15072 | |
| MAQLWLSCFLLPALV | 1 | Q9BYE9 | |
| LLIIAVLMWLPSSVI | 376 | Q8WUS8 | |
| MPVLLLTGLFLLVWN | 26 | P11511 | |
| MDLWQLLLTLALAGS | 1 | P10912 | |
| SSLVAPVMWLSVALL | 106 | Q8N5C1 | |
| ASVIWLLFDMAALRL | 21 | Q7Z7M9 | |
| LLLLLVAASLLAWRM | 166 | Q8TDQ1 | |
| MSLLSLSWLGLRPVA | 1 | P98187 | |
| MSISLSSLILLPIWI | 1 | Q8WUF8 | |
| MLGSRAVMLLLLLPW | 1 | Q9NPF7 | |
| MTPQLLLALVLWASC | 1 | Q14213 | |
| MAAPALSWRLPLLIL | 1 | P14784 | |
| MPWALLLLTLLTHSA | 1 | A0A075B6I4 | |
| MWQLLLPTALLLLVS | 1 | O75015 | |
| AAWTAVLAALMALLI | 31 | Q9Y5N1 | |
| MRFAWTVLLLGPLQL | 1 | P28300 | |
| MALSWVLTVLSLLPL | 1 | P02763 | |
| METPAQLLFLLLLWL | 1 | P01619 | |
| LWALQLIMVSTPSLL | 76 | Q6PEY0 | |
| LAVADLLVATLVMPW | 76 | P14416 | |
| SLALLTGALWLMNEL | 391 | Q7KZN9 | |
| MAWPLCTLLLLLATQ | 1 | P09228 | |
| MAARPAATLAWSLLL | 1 | Q8IYK4 | |
| MWQLLLPTALLLLVS | 1 | P08637 | |
| MLFSALLLEVIWILA | 1 | Q9ULX7 | |
| GSLPAWLIILISSLM | 466 | Q9BZW2 | |
| RAMIKSLPLWAILVS | 286 | Q9Y2C5 | |
| LGLVLPMWAIALISF | 206 | Q08357 | |
| PMWAIALISFGVALL | 211 | Q08357 | |
| MVPAAGALLWVLLLN | 1 | Q9BUN1 | |
| MWLAAAAPSLARRLL | 1 | P55786 | |
| MGPWSRSLSALLLLL | 1 | P12830 | |
| LAVADLLVATLVMPW | 71 | P35462 | |
| AWPFLLSLALMLLWL | 241 | P15328 | |
| DTALALWIPSLLMSA | 161 | Q53RY4 | |
| LWIPSLLMSAGEAAL | 166 | Q53RY4 | |
| ITILFWPLSMILLSD | 6 | Q9H756 | |
| MAWALLLLSLLTQGT | 1 | P01706 | |
| ALPSVSWMLLSCLIL | 6 | Q6UW15 | |
| MAWALLLLTLLTQGT | 1 | P01704 | |
| SKPLIMLLSNSSWRL | 11 | Q8NGH7 | |
| MEFVRALWLGLALAL | 1 | O60391 | |
| MAPLGTTVLLWSLLR | 1 | P82650 | |
| TWIEATLPLRMLLIA | 916 | Q9HCH5 | |
| LMPWLLRLSVLVSLS | 141 | P59535 | |
| ATAVLSLLIMLGTLW | 556 | Q8NBS3 | |
| MRWALAVLLAFLSPA | 1 | A0A0A0MS02 | |
| MQWALAVLLAFLSPA | 1 | A0A075B6R0 | |
| IFVPLWLSLITLMAT | 246 | Q8NFB2 | |
| IFVPLWLSLLTLMAT | 246 | Q9H7F4 | |
| MAAAPGLLVWLLVLR | 1 | Q5JRA6 | |
| MAWALLLLTLLTQGT | 1 | P01709 | |
| SVLLDVALGLMLLSW | 281 | Q9BRB3 | |
| MRWALLVLLAFLSPA | 1 | P03979 | |
| MRWALLVLLAFLSPA | 1 | A0A0B4J1U4 | |
| NLLTWIVLLSMPSLI | 821 | Q75T13 | |
| RAMVTVLAFLWLPSL | 931 | P08514 | |
| AAAWVLSLCMSLPLL | 161 | P35346 | |
| MAETLFWTPLLVVLL | 1 | Q16586 | |
| RWAAMSLISLFLPCL | 221 | O43610 | |
| CWLFLSPATLLALMV | 501 | Q99884 | |
| ALVTWVPMFLSTLLA | 166 | O75908 | |
| MAWASRLGLLLALLL | 1 | Q8N4F0 | |
| SALLLMLFCVALWPV | 201 | E7ERA6 | |
| RISKLVPWMILGSLL | 121 | Q9NYW7 | |
| MLPWTALGLALSLRL | 1 | Q6PCB0 | |
| ATLALFRLVPLGWMS | 171 | A6NGC4 | |
| MNKPLLWISVLTSLL | 1 | P02743 | |
| MLGIWTLLPLVLTSV | 1 | P25445 | |
| TLLALLLMIITFWLP | 11 | P03897 | |
| TPFEISLWILLACLM | 101 | P19634 | |
| MQWALAVLLAFLSPA | 1 | A0A0C4DH28 | |
| LRWMALIALSFLAPC | 376 | Q7Z698 | |
| WQMLSLSLGLVLAIL | 6 | O94813 | |
| SLILIVIMFLWRPSA | 441 | Q96K49 | |
| EWPLNRALLMTFSLL | 191 | Q5GH77 | |
| AALALALWLLMPPVE | 6 | Q13445 | |
| LGLALLSALQALMPW | 216 | Q7Z403 | |
| GSLVLPVLVFLWAML | 1706 | Q92508 | |
| IWLFSAHMLPLLARL | 146 | Q96MT1 | |
| WAFSLLPLDVDLLSM | 141 | Q9H267 | |
| WSLPEMASVGLLLAI | 211 | Q8NHX9 | |
| MAAAAWLQVLPVILL | 1 | Q8NBN3 | |
| RSWALLALWPLLSLM | 216 | Q66K66 | |
| LALWPLLSLMGVLVQ | 221 | Q66K66 | |
| MAPISLSWLLRLATF | 1 | P78423 | |
| TSAAWAILPLLLLVM | 796 | P98155 | |
| LPLLMAQLWAAEAAL | 21 | O43240 | |
| MAPASRLLALWALAA | 1 | Q96S16 | |
| ALWTVLAAPLLMSTD | 271 | P17050 |